Cognitive impairment, including Alzheimer's disease and other kinds of dementia, is a major health problem in older adults worldwide. Although numerous investigators have attempted to develop effective treatment modalities or drugs, there is no reasonably efficacious strategy for preventing or recovering from cognitive impairment. Therefore, modifiable risk factors for cognitive impairment have received attention, and the growing literature of metabolic risk factors for cognitive impairment has expanded from epidemiology to molecular pathogenesis and therapeutic management. This review focuses on the epidemiological evidence for the association between cognitive impairment and several endocrine risk factors, including insulin resistance, dyslipidemia, thyroid dysfunction, vitamin D deficiency, and subclinical atherosclerosis. Researches suggesting possible mechanisms for this association are reviewed. The research investigating modifiable endocrine risk factors for cognitive impairment provides clues for understanding the pathogenesis of cognitive impairment and developing novel treatment modalities. However, so far, interventional studies investigating the beneficial effect of the "modification" of these "modifiable risk factors" on cognitive impairment have reported variable results. Therefore, well-designed, randomized prospective interventional studies are needed.

Citations

Citations to this article as recorded by  

• Association between the neutrophil to lymphocyte ratio and mild cognitive impairment in patients with type 2 diabetes
  Zi-Wei Yu, Ying Wang, Xin Li, Xue-Wei Tong, Yi-Tong Zhang, Xin-Yuan Gao
  Aging Clinical and Experimental Research.2023; 35(6): 1339.     CrossRef
• Cognitive status and its risk factors in patients with hypertension and diabetes in a low‐income rural area of China: A cross‐sectional study
  Yuyan Guo, Ruifeng Liang, Jingjuan Ren, Liting Cheng, Mengqin Wang, Huilin Chai, Xiaoyu Cheng, Yaowen Yang, Yajuan Sun, Jiantao Li, Shuhong Zhao, Wenjing Hou, Jianhua Zhang, Feng Liu, Rong Wang, Qiao Niu, Hongmei Yu, Shoulin Yang, Jianying Bai, Hongmei Zh
  International Journal of Geriatric Psychiatry.2023;[Epub]     CrossRef
• Insulin Resistance and Glucose Metabolism during Infection
  Borros Arneth
  Endocrines.2023; 4(4): 685.     CrossRef
• Relationship between serum lipids and depression: A cross sectional survey among adults in Haryana, India
  Rubina Mulchandani, Tanica Lyngdoh, Ria Nangia, Sukriti Singh, Sandeep Grover, JS Thakur
  Indian Journal of Psychiatry.2023; 65(1): 61.     CrossRef
• Corresponding risk factors between cognitive impairment and type 1 diabetes mellitus: A narrative review
  Chen-Yang Jin, Shi-Wen Yu, Jun-Ting Yin, Xiao-Ying Yuan, Xu-Gang Wang
  Heliyon.2022; 8(8): e10073.     CrossRef
• Cerebrospinal fluid heart fatty acid‐binding protein as a predictive biomarker of neurodegeneration in Alzheimer’s disease
  Lu Pan, Ya-Nan Ou, Lin Tan, Lan Tan, Jin-Tai Yu
  Brain Science Advances.2021; 7(1): 44.     CrossRef
• Endocrine dysfunction and cognitive impairment
  Valeria CALSOLARO, Marina BOTTARI, Giulia COPPINI, Bianca LEMMI, Fabio MONZANI
  Minerva Endocrinology.2021;[Epub]     CrossRef
• Effect of hypothyroidism on cognitive status: Evidence from stroop task
  Shilpi Goyal, Abhinav Dixit, Neelam Vaney, SV Madhu
  Indian Journal of Medical Specialities.2020; 11(1): 34.     CrossRef
• Statin use and safety concerns: an overview of the past, present, and the future
  Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
  Expert Opinion on Drug Safety.2020; 19(8): 1011.     CrossRef
• Neurocognitive impairment in type 2 diabetes mellitus
  Marianna Karvani, P. Simos, S. Stavrakaki, D. Kapoukranidou
  Hormones.2019; 18(4): 523.     CrossRef
• TDP-43 proteinopathy in aging: Associations with risk-associated gene variants and with brain parenchymal thyroid hormone levels
  Peter T. Nelson, Zsombor Gal, Wang-Xia Wang, Dana M. Niedowicz, Sergey C. Artiushin, Samuel Wycoff, Angela Wei, Gregory A. Jicha, David W. Fardo
  Neurobiology of Disease.2019; 125: 67.     CrossRef
• Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults
  Willa D. Brenowitz, Fang Han, Walter A. Kukull, Peter T. Nelson
  Neurobiology of Aging.2018; 62: 64.     CrossRef
• Translating molecular advances in Down syndrome and Fragile X syndrome into therapies
  Victor Faundez, Ilario De Toma, Barbara Bardoni, Renata Bartesaghi, Dean Nizetic, Rafael de la Torre, Roi Cohen Kadosh, Yann Herault, Mara Dierssen, Marie-Claude Potier, Stylianos Antonarakis, Renata Bartesaghi, Andrea Contestabile, Tonnie Coppus, Peter D
  European Neuropsychopharmacology.2018; 28(6): 675.     CrossRef
• Associations between waist circumference, metabolic risk and executive function in adolescents: A cross-sectional mediation analysis
  Anna Bugge, Sören Möller, Daniel R. Westfall, Jakob Tarp, Anne K. Gejl, Niels Wedderkopp, Charles H. Hillman, Ying-Mei Feng
  PLOS ONE.2018; 13(6): e0199281.     CrossRef
• BsmI polymorphism in the vitamin D receptor gene is associated with 25-hydroxy vitamin D levels in individuals with cognitive decline
  Ana Carolina R. de Oliveira, Carolina A. Magalhães, Cristina M. G. Loures, Vanessa G. Fraga, Leonardo C. de Souza, Henrique C. Guimarães, Marco T. G. Cintra, Maria A. Bicalho, Maira C. R. Sousa, Josianne N. Silveira, Ieda F. O. Silva, Paulo Caramelli, Mar
  Arquivos de Neuro-Psiquiatria.2018; 76(11): 760.     CrossRef
• Traumatic brain injury: sex, gender and intersecting vulnerabilities
  Tatyana Mollayeva, Shirin Mollayeva, Angela Colantonio
  Nature Reviews Neurology.2018; 14(12): 711.     CrossRef
• Determinants of poor cognitive function using A-IQCODE among Lebanese older adults: a cross-sectional study
  Ibrahim R. Bou-Orm, Assem M. Khamis, Monique Chaaya
  Aging & Mental Health.2018; 22(6): 844.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Alcohol consumption and gastric cancer risk: a meta-analysis of prospective cohort studies
  Xue Han, Li Xiao, Yao Yu, Yu Chen, Hai-Hua Shu
  Oncotarget.2017; 8(47): 83237.     CrossRef
• Functional capacity and obesity reflect the cognitive performance of older adults living in long‐term care facilities
  Karine Gonçalves Damascena, Cristiane Batisti Ferreira, Pâmela dos Santos Teixeira, Bibiano Madrid, Alexandre Gonçalves, Cláudio Córdova, Otávio de Toledo Nóbrega, Aparecido Pimentel Ferreira
  Psychogeriatrics.2017; 17(6): 439.     CrossRef
• Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease
  Therese S Salameh, Elizabeth M Rhea, William A Banks, Angela J Hanson
  Experimental Biology and Medicine.2016; 241(15): 1676.     CrossRef
• Role of the Orexin System on the Hypothalamus-Pituitary-Thyroid Axis
  Antonietta Messina, Carolina De Fusco, Vincenzo Monda, Maria Esposito, Fiorenzo Moscatelli, Anna Valenzano, Marco Carotenuto, Emanuela Viggiano, Sergio Chieffi, Vincenzo De Luca, Giuseppe Cibelli, Marcellino Monda, Giovanni Messina
  Frontiers in Neural Circuits.2016;[Epub]     CrossRef
• Genomics and CSF analyses implicate thyroid hormone in hippocampal sclerosis of aging
  Peter T. Nelson, Yuriko Katsumata, Kwangsik Nho, Sergey C. Artiushin, Gregory A. Jicha, Wang-Xia Wang, Erin L. Abner, Andrew J. Saykin, Walter A. Kukull, David W. Fardo
  Acta Neuropathologica.2016; 132(6): 841.     CrossRef

Kisspeptin signaling at the gonadotropin-releasing hormone (GnRH) neuron is now relatively well characterized and established as being critical for the neural control of fertility. However, kisspeptin fibers and the kisspeptin receptor (KISS1R) are detected throughout the brain suggesting that kisspeptin is involved in regulating the activity of multiple neuronal circuits. We provide here a review of kisspeptin actions on neuronal populations throughout the brain including the magnocellular oxytocin and vasopressin neurons, and cells within the arcuate nucleus, hippocampus, and amygdala. The actions of kisspeptin in these brain regions are compared to its effects upon GnRH neurons. Two major themes arise from this analysis. First, it is apparent that kisspeptin signaling through KISS1R at the GnRH neuron is a unique, extremely potent form or neurotransmission whereas kisspeptin actions through KISS1R in other brain regions exhibit neuromodulatory actions typical of other neuropeptides. Second, it is becoming increasingly likely that kisspeptin acts as a neuromodulator not only through KISS1R but also through other RFamide receptors such as the neuropeptide FF receptors (NPFFRs). We suggest likely locations of kisspeptin signaling through NPFFRs but note that only limited tools are presently available for examining kisspeptin cross-signaling within the RFamide family of neuropeptides.

Citations

Citations to this article as recorded by  

• Role of the histone variant H2A.Z.1 in memory, transcription, and alternative splicing is mediated by lysine modification
  Anas Reda, Luca A. Hategan, Timothy A. B. McLean, Samantha D. Creighton, Jian Qi Luo, Sean En Si Chen, Shan Hua, Stephen Winston, Isaiah Reeves, Aditya Padmanabhan, Tarkan A. Dahi, Firyal Ramzan, Mark A. Brimble, Patrick J. Murphy, Brandon J. Walters, Gil
  Neuropsychopharmacology.2024; 49(8): 1285.     CrossRef
• System-wide mapping of peptide-GPCR interactions in C. elegans
  Isabel Beets, Sven Zels, Elke Vandewyer, Jonas Demeulemeester, Jelle Caers, Esra Baytemur, Amy Courtney, Luca Golinelli, İlayda Hasakioğulları, William R. Schafer, Petra E. Vértes, Olivier Mirabeau, Liliane Schoofs
  Cell Reports.2023; 42(9): 113058.     CrossRef
• Impose of KNDy/GnRH neural circuit in PCOS, ageing, cancer and Alzheimer’s disease: StAR actions in prevention of neuroendocrine dysfunction
  Siva Prasad Panda, Adarsh Kesharwani, Gaurav Deep Singh, DSNBK Prasanth, Bhaskara Raju Vatchavai, P.V. Kamala Kumari, Sunil Kumar Panda, Sarada Prasanna Mallick
  Ageing Research Reviews.2023; 92: 102086.     CrossRef
• Gallium-68-Labeled KISS1-54 Peptide for Mapping KISS1 Receptor via PET: Initial Evaluation in Human Tumor Cell Lines and in Tumor-Bearing Mice
  Ina Israel, Gabriele Riehl, Elke Butt, Andreas K. Buck, Samuel Samnick
  Pharmaceuticals.2023; 17(1): 44.     CrossRef
• Effects of probiotic supplementation on semen parameters after varicocelectomy: A randomized controlled trial
  Mousa Asadi, Farshad Gholipour, Amirhossein Rahavian, Mohammad Javanbakht
  Journal of Research in Medical Sciences.2023;[Epub]     CrossRef
• Kisspeptin-13 prevented the electrophysiological alterations induced by amyloid-beta pathology in rat: Possible involvement of stromal interaction molecules and pCREB
  Shima Ebrahimi Khonacha, Seyed Hamidreza Mirbehbahani, Mona Rahdar, Shima Davoudi, Mehdi Borjkhani, Fariba Khodagholi, Fereshteh Motamedi, Mahyar Janahmadi
  Brain Research Bulletin.2022; 184: 13.     CrossRef
• Sexual Dimorphism in Kisspeptin Signaling
  Eun Bee Lee, Iman Dilower, Courtney A. Marsh, Michael W. Wolfe, Saeed Masumi, Sameer Upadhyaya, Mohammad A. Karim Rumi
  Cells.2022; 11(7): 1146.     CrossRef
• Estradiol and progesterone-induced lordosis behavior is modulated by both the Kisspeptin receptor and melanin-concentrating hormone in estradiol benzoate-primed rats
  Oscar González-Flores, James G. Pfaus, Ailyn Luna-Hernández, Omar Montes-Narváez, Raymundo Domínguez-Ordóñez, Miriam B. Tecamachaltzi-Silvarán, Marcos García-Juárez
  Hormones and Behavior.2022; 146: 105257.     CrossRef
• Targeting KNDy neurons to control GnRH pulses
  Stephanie Constantin
  Current Opinion in Pharmacology.2022; 67: 102316.     CrossRef
• The ameliorative effects of Lactobacillus coagulans and Lactobacillus casei probiotics on CCl4‐induced testicular toxicity based on biochemical, histological and molecular analyses in rat
  Zahra Keshtmand, Mohsen Akbaribazm, Yasin Bagheri, Reyhaneh Oliaei
  Andrologia.2021;[Epub]     CrossRef
• Nitric oxide resets kisspeptin-excited GnRH neurons via PIP2 replenishment
  Stephanie Constantin, Daniel Reynolds, Andrew Oh, Katherine Pizano, Susan Wray
  Proceedings of the National Academy of Sciences.2021;[Epub]     CrossRef
• Expression analysis of neuropeptide FF receptors on neuroendocrine-related neurons in the rat brain using highly sensitive in situ hybridization
  Shimpei Higo, Moeko Kanaya, Hitoshi Ozawa
  Histochemistry and Cell Biology.2021; 155(4): 465.     CrossRef
• Timing the Juvenile-Adult Neurohormonal Transition: Functions and Evolution
  Celia G. Barredo, Beatriz Gil-Marti, Derya Deveci, Nuria M. Romero, Francisco A. Martin
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Kisspeptin-54 attenuates oxidative stress and neuronal apoptosis in early brain injury after subarachnoid hemorrhage in rats via GPR54/ARRB2/AKT/GSK3β signaling pathway
  Yi Huang, Yong Guo, Lei Huang, Yuanjian Fang, Dujuan Li, Rui Liu, Qin Lu, Reng Ren, Lihui Tang, Lifei Lian, Yongmei Hu, Jiping Tang, Gao Chen, John H. Zhang
  Free Radical Biology and Medicine.2021; 171: 99.     CrossRef
• Conditioned place preference of kisspeptin-10
  Ilia Yu. Tissen, Polina A. Chepik, Andrei A. Lebedev, Leila A. Magarramova, Eugenii R. Bychkov, Petr D. Shabanov
  Reviews on Clinical Pharmacology and Drug Therapy.2021; 19(1): 47.     CrossRef
• Expression of type one cannabinoid receptor in different subpopulation of kisspeptin neurons and kisspeptin afferents to GnRH neurons in female mice
  Tamás Wilheim, Krisztina Nagy, Mahendravarman Mohanraj, Kamil Ziarniak, Masahiko Watanabe, Joanna Sliwowska, Imre Kalló
  Brain Structure and Function.2021; 226(7): 2387.     CrossRef
• Dopamine D2 Receptor Antagonist Alters the Testosterone Release and Kisspeptin/GPR54 Signaling in Food-Restricted Rats
  Khatereh Nourmohammadi, Farrin Babaei-Balderlou, Seyyed Meysam Abtahi-Foroushani
  Iranian Journal of Science and Technology, Transactions A: Science.2021; 45(6): 1879.     CrossRef
• Astrocytic Hydrogen Sulfide Regulates Supraoptic Cellular Activity in the Adaptive Response of Lactating Rats to Chronic Social Stress
  Dongyang Li, Haitao Liu, Hongyang Wang, Shuwei Jia, Xiaoran Wang, Shuo Ling, Guichuan Chen, Xiaoyu Liu, Yu-Feng Wang
  ASN Neuro.2021; 13: 175909142110430.     CrossRef
• Experimental characterization of a biosensor based on a tapered optical fiber for kisspeptin detection
  K. González-León, G. Beltrán-Pérez, S. Muñoz-Aguirre, V. López -Gayou, J. Castillo-Mixcoatl, V. Alatriste, R. Delgado-Macuil
  Applied Optics.2020; 59(13): D131.     CrossRef
• Cloning, characterisation and expression profile of kisspeptin1 and the kisspeptin1 receptor in the hypothalamic–pituitary–ovarian axis of Chinese alligator Alligator sinensis during the reproductive cycle
  Ruidong Zhang, Haitao Nie, Shulong Duan, Peng Yan, Ali Izaz, Renping Wang, Yongkang Zhou, Xiaobing Wu
  Reproduction, Fertility and Development.2020; 32(8): 792.     CrossRef
• Multiple failures in the lutenising hormone surge generating system in GABAB1KO female mice
  Noelia P. Di Giorgio, Marianne Bizzozzero Hiriart, Pablo N. Surkin, Paula V. López, Nadia S. Bourguignon, Verónica B. Dorfman, Bernhard Bettler, Carlos Libertun, Victoria Lux‐Lantos
  Journal of Neuroendocrinology.2019;[Epub]     CrossRef
• Vasopressin regulates hypothalamic GnRH synthesis: Histomorphological evidence in hypothalamus and biological effects in GT1-7 cells
  Zhu Zhu, Xiaozhen Zhao, Feng Huang, Feng Wang, Wei Wang
  Life Sciences.2019; 227: 166.     CrossRef
• The kisspeptin derivative kissorphin reduces the acquisition, expression, and reinstatement of ethanol-induced conditioned place preference in rats
  Ewa Gibula-Tarlowska, Pawel Grochecki, Jerzy Silberring, Jolanta H. Kotlinska
  Alcohol.2019; 81: 11.     CrossRef
• Unraveling the connection between GABA and kisspeptin in the control of reproduction
  Noelia P Di Giorgio, Marianne Bizzozzero-Hiriart, Carlos Libertun, Victoria Lux-Lantos
  Reproduction.2019; 157(6): R225.     CrossRef
• Region-specific changes in brain kisspeptin receptor expression during estrogen depletion and the estrous cycle
  Saeko Ozaki, Shimpei Higo, Kinuyo Iwata, Hidehisa Saeki, Hitoshi Ozawa
  Histochemistry and Cell Biology.2019; 152(1): 25.     CrossRef
• The long and the short of it – a perspective on peptidergic regulation of circuits and behaviour
  Gáspár Jékely, Sarah Melzer, Isabel Beets, Ilona C. Grunwald Kadow, Joris Koene, Sara Haddad, Lindy Holden-Dye
  Journal of Experimental Biology.2018;[Epub]     CrossRef
• Biological Significance of Kisspeptin–Kiss 1 Receptor Signaling in the Habenula of Teleost Species
  Satoshi Ogawa, Ishwar S. Parhar
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• Analysis of gonadotrophin‐releasing hormone‐1 and kisspeptin neuronal systems in the nonphotoregulated seasonally breeding eastern rock elephant‐shrew (Elephantulus myurus)
  Katarina Medger, Nigel C. Bennett, Christian T. Chimimba, Maria K. Oosthuizen, Jens D. Mikkelsen, Clive W. Coen
  Journal of Comparative Neurology.2018; 526(15): 2388.     CrossRef
• Altered aspects of anxiety-related behavior in kisspeptin receptor-deleted male mice
  Sarah Delmas, Robert Porteous, Dave H. Bergin, Allan E. Herbison
  Scientific Reports.2018;[Epub]     CrossRef
• Effect of long-term treatment with classical neuroleptics on NPQ/spexin, kisspeptin and POMC mRNA expression in the male rat amygdala
  Artur Pałasz, Marcelina Pałka, Łukasz Filipczyk, Itiana Castro Menezes, Ewa Rojczyk, John J. Worthington, Aneta Piwowarczyk-Nowak, Marek Krzystanek, Ryszard Wiaderkiewicz
  Journal of Neural Transmission.2018; 125(7): 1099.     CrossRef
• Integrative neurohumoural regulation of oxytocin neurone activity in pregnancy and lactation
  R. A. Augustine, A. J. Seymour, R. E. Campbell, D. R. Grattan, C. H. Brown
  Journal of Neuroendocrinology.2018;[Epub]     CrossRef
• Towards new strategies to manage livestock reproduction using kisspeptin analogs
  M. Beltramo, C. Decourt
  Theriogenology.2018; 112: 2.     CrossRef
• キスペプチン神経系機能における脊椎動物間での多様性と普遍性
  
  Comparative Endocrinology.2018; 44(163): 15.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Kisspeptin as a promising oocyte maturation trigger for in vitro fertilisation in humans
  Miro Kasum, Daniela Franulić, Ermin Čehić, Slavko Orešković, Albert Lila, Emina Ejubović
  Gynecological Endocrinology.2017; 33(8): 583.     CrossRef
• The association of a probiotic with a prebiotic (Flortec, Bracco) to improve the quality/quantity of spermatozoa in infertile patients with idiopathic oligoasthenoteratospermia: a pilot study
  C. Maretti, G. Cavallini
  Andrology.2017; 5(3): 439.     CrossRef
• Cyclic ADP-Ribose and Heat Regulate Oxytocin Release via CD38 and TRPM2 in the Hypothalamus during Social or Psychological Stress in Mice
  Jing Zhong, Sarwat Amina, Mingkun Liang, Shirin Akther, Teruko Yuhi, Tomoko Nishimura, Chiharu Tsuji, Takahiro Tsuji, Hong-Xiang Liu, Minako Hashii, Kazumi Furuhara, Shigeru Yokoyama, Yasuhiko Yamamoto, Hiroshi Okamoto, Yong Juan Zhao, Hon Cheung Lee, Mak
  Frontiers in Neuroscience.2016;[Epub]     CrossRef
• Role of the Kiss1/Kiss1r system in the regulation of pituitary cell function
  Manuel D. Gahete, Mari C. Vázquez-Borrego, Antonio J. Martínez-Fuentes, Manuel Tena-Sempere, Justo P. Castaño, Raúl M. Luque
  Molecular and Cellular Endocrinology.2016; 438: 100.     CrossRef

Bone metastasis is a frequent occurrence in breast cancer, affecting more than 70% of late stage cancer patients with severe complications such as fracture, bone pain, and hypercalcemia. The pathogenesis of osteolytic bone metastasis depends on cross-communications between tumor cells and various stromal cells residing in the bone microenvironment. Several growth factor signaling pathways, secreted micro RNAs (miRNAs) and exosomes are functional mediators of tumor-stromal interactions in bone metastasis. We developed a functional genomic approach to systemically identified molecular pathways utilized by breast cancer cells to engage the bone stroma in order to generate osteolytic bone metastasis. We showed that elevated expression of vascular cell adhesion molecule 1 (VCAM1) in disseminated breast tumor cells mediates the recruitment of pre-osteoclasts and promotes their differentiation to mature osteoclasts during the bone metastasis formation. Transforming growth factor β (TGF-β) is released from bone matrix upon bone destruction, and signals to breast cancer to further enhance their malignancy in developing bone metastasis. We furthered identified Jagged1 as a TGF-β target genes in tumor cells that engaged bone stromal cells through the activation of Notch signaling to provide a positive feedback to promote tumor growth and to activate osteoclast differentiation. Substantially change in miRNA expression was observed in osteoclasts during their differentiation and maturation, which can be exploited as circulating biomarkers of emerging bone metastasis and therapeutic targets for the treatment of bone metastasis. Further research in this direction may lead to improved diagnosis and treatment strategies for bone metastasis.

Citations

Citations to this article as recorded by  

• Osteoclast Cancer Cell Metabolic Cross-talk Confers PARP Inhibitor Resistance in Bone Metastatic Breast Cancer
  Huijuan Fan, Zhanao Xu, Ke Yao, Bingxin Zheng, Yuan Zhang, Xuxiang Wang, Tengjiang Zhang, Xuan Li, Haitian Hu, Bin Yue, Zeping Hu, Hanqiu Zheng
  Cancer Research.2024; 84(3): 449.     CrossRef
• Immune mediated support of metastasis: Implication for bone invasion
  Zengfeng Xin, Luying Qin, Yang Tang, Siyu Guo, Fangfang Li, Yuan Fang, Gege Li, Yihan Yao, Binbin Zheng, Bicheng Zhang, Dang Wu, Jie Xiao, Chao Ni, Qichun Wei, Ting Zhang
  Cancer Communications.2024; 44(9): 967.     CrossRef
• Krüppel‐like factors family in health and disease
  Tingwen Xiang, Chuan Yang, Zihan Deng, Dong Sun, Fei Luo, Yueqi Chen
  MedComm.2024;[Epub]     CrossRef
• Bone Marrow Mesenchymal Stem Cells Restrain the Migration and Invasion of Breast Cancer Cells by Up-Regulating miR-2158 and Inactivating RAI2/NLRP3 Pathway
  Meiyu Xu, Shen Ye, Zhiqiang Tang, Shuai Gong
  Journal of Biomaterials and Tissue Engineering.2023; 13(1): 162.     CrossRef
• Association of RANKL and EGFR gene expression with bone metastases in patients with metastatic non-small cell lung cancer
  Anita J.W.M. Brouns, Lizza E.L. Hendriks, Iris J. Robbesom-van den Berge, Annemariek J.H.M. Driessen, Guido M.J.M. Roemen, Britt L.J. van Herpen, Zoë Dekkers, Bas Heitzer, Daphne J.G. Leunissen, Laura Moonen, Ragnar Lunde, Marcel Westenend, Marjolein van
  Frontiers in Oncology.2023;[Epub]     CrossRef
• BMAL1 induces colorectal cancer metastasis by stimulating exosome secretion
  Pengjuan Dong, Yaping Wang, Yutong Liu, Chunting Zhu, Jiaxin Lin, Ruizhe Qian, Luchun Hua, Chao Lu
  Molecular Biology Reports.2022; 49(1): 373.     CrossRef
• Chemokines network in bone metastasis: Vital regulators of seeding and soiling
  Gunjan Sharma, Ramesh Pothuraju, Ranjana Kumari Kanchan, Surinder Kumar Batra, Jawed Akhtar Siddiqui
  Seminars in Cancer Biology.2022; 86: 457.     CrossRef
• The Signaling Pathways Associated With Breast Cancer Bone Metastasis
  Xuelian Song, Changran Wei, Xiangqi Li
  Frontiers in Oncology.2022;[Epub]     CrossRef
• Effects of 8-Week Noncontinuous Aerobic Exercise on the Levels of CCL2, CCL5, and their Respective Receptors in Female BALB/C Mice Suffering from Breast Cancer
  Mehrnoosh Esmailiyan, Mehdi Kargarfard, Fahimeh Esfarjani, Golnaz Vaseghi
  International Journal of Preventive Medicine.2022; 13(1): 55.     CrossRef
• Non‐coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance
  Margherita Puppo, Hanna Taipaleenmäki, Eric Hesse, Philippe Clézardin
  British Journal of Pharmacology.2021; 178(9): 1936.     CrossRef
• Sympathetic activity in breast cancer and metastasis: partners in crime
  Francisco Conceição, Daniela M. Sousa, Joana Paredes, Meriem Lamghari
  Bone Research.2021;[Epub]     CrossRef
• Extracellular Vesicles in Tumors: A Potential Mediator of Bone Metastasis
  Shenglong Li, Wei Wang
  Frontiers in Cell and Developmental Biology.2021;[Epub]     CrossRef
• Bone marrow niches in the regulation of bone metastasis
  Fenfang Chen, Yujiao Han, Yibin Kang
  British Journal of Cancer.2021; 124(12): 1912.     CrossRef
• Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer
  Kerui Wu, Jiamei Feng, Feng Lyu, Fei Xing, Sambad Sharma, Yin Liu, Shih-Ying Wu, Dan Zhao, Abhishek Tyagi, Ravindra Pramod Deshpande, Xinhong Pei, Marco Gabril Ruiz, Hiroyuki Takahashi, Shunsuke Tsuzuki, Takahiro Kimura, Yin-yuan Mo, Yusuke Shiozawa, Ravi
  Nature Communications.2021;[Epub]     CrossRef
• Circulating Osteocalcin-Positive Cells as a Novel Diagnostic Biomarker for Bone Metastasis in Breast Cancer Patients
  Kyung-Hun Lee, Kyoung Jin Lee, Tae-Yong Kim, Febby Hutomo, Hyun Jin Sun, Gi Jeong Cheon, Serk In Park, Sun Wook Cho, Seock-Ah Im
  Journal of Bone and Mineral Research.2020; 35(10): 1838.     CrossRef
• Polymer nanomedicines
  Jindřich Kopeček, Jiyuan Yang
  Advanced Drug Delivery Reviews.2020; 156: 40.     CrossRef
• Osteolytic metastasis in breast cancer: effective prevention strategies
  Chandi C Mandal
  Expert Review of Anticancer Therapy.2020; 20(9): 797.     CrossRef
• The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies
  Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele, Matteo Fassan
  International Journal of Molecular Sciences.2020; 21(21): 8102.     CrossRef
• Identification and validation of DOCK4 as a potential biomarker for risk of bone metastasis development in patients with early breast cancer
  Jules A Westbrook, Steven L Wood, David A Cairns, Kathryn McMahon, Renu Gahlaut, Helene Thygesen, Mike Shires, Stephanie Roberts, Helen Marshall, Maria R Oliva, Mark J Dunning, Andrew M Hanby, Peter J Selby, Valerie Speirs, Georgia Mavria, Robert E Colema
  The Journal of Pathology.2019; 247(3): 381.     CrossRef
• The Relationship between Exosomes and Cancer: Implications for Diagnostics and Therapeutics
  Wendy W. Weston, Timothy Ganey, H. Thomas Temple
  BioDrugs.2019; 33(2): 137.     CrossRef
• In Vivo Assessment of VCAM-1 Expression by SPECT/CT Imaging in Mice Models of Human Triple Negative Breast Cancer
  Christopher Montemagno, Laurent Dumas, Pierre Cavaillès, Mitra Ahmadi, Sandrine Bacot, Marlène Debiossat, Audrey Soubies, Loic Djaïleb, Julien Leenhardt, Nicolas De Leiris, Maeva Dufies, Gilles Pagès, Sophie Hernot, Nick Devoogdt, Pascale Perret, Laurent
  Cancers.2019; 11(7): 1039.     CrossRef
• Notch and breast cancer metastasis: Current knowledge, new sights and targeted therapy (Review)
  Yu Zhang, Zi‑Yan Xie, Xuan‑Tong Guo, Xing‑Hua Xiao, Li‑Xia Xiong
  Oncology Letters.2019;[Epub]     CrossRef
• NPNT promotes early-stage bone metastases in breast cancer by regulation of the osteogenic niche
  Dongsheng Wang, Chenglong Zhao, Liangliang Gao, Yao Wang, Xin Gao, Liang Tang, Kun Zhang, Zhenxi Li, Jing Han, Jianru Xiao
  Journal of Bone Oncology.2018; 13: 91.     CrossRef
• Placental exosomes: A proxy to understand pregnancy complications
  Jin Jin, Ramkumar Menon
  American Journal of Reproductive Immunology.2018;[Epub]     CrossRef
• Understanding the Bone in Cancer Metastasis
  Jaime Fornetti, Alana L Welm, Sheila A Stewart
  Journal of Bone and Mineral Research.2018; 33(12): 2099.     CrossRef
• Role of Tumor-Derived Chemokines in Osteolytic Bone Metastasis
  Salvatore J. Coniglio
  Frontiers in Endocrinology.2018;[Epub]     CrossRef
• The role of exosomes in cancer metastasis
  Teresa Bernadette Steinbichler, József Dudás, Herbert Riechelmann, Ira-Ida Skvortsova
  Seminars in Cancer Biology.2017; 44: 170.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Impaired Bone Matrix Alignment Induced by Breast Cancer Metastasis
  Aiko Sekita, Aira Matsugaki, Takayoshi Nakano
  Journal of the Japan Institute of Metals.2017; 81(6): 308.     CrossRef
• SMURF2 regulates bone homeostasis by disrupting SMAD3 interaction with vitamin D receptor in osteoblasts
  Zhan Xu, Matthew B. Greenblatt, Guang Yan, Heng Feng, Jun Sun, Sutada Lotinun, Nicholas Brady, Roland Baron, Laurie H. Glimcher, Weiguo Zou
  Nature Communications.2017;[Epub]     CrossRef
• Bone Microenvironment and Role of Rank-Rankl-Opg in Breast Cancer Metastasis in Bone
  Hongwei Zhang
  Journal of Cancer Prevention & Current Research.2017;[Epub]     CrossRef
• Tumor–Stroma Interactions in Bone Metastasis: Molecular Mechanisms and Therapeutic Implications
  Hanqiu Zheng, Wenyang Li, Yibin Kang
  Cold Spring Harbor Symposia on Quantitative Biology.2016; 81: 151.     CrossRef
• Breast cancer cells obtain an osteomimetic featureviaepithelial-mesenchymal transition that have undergone BMP2/RUNX2 signaling pathway induction
  Cong-Cong Tan, Gui-Xi Li, Li-Duan Tan, Xin Du, Xiao-Qing Li, Rui He, Qing-Shan Wang, Yu-Mei Feng
  Oncotarget.2016; 7(48): 79688.     CrossRef
• Heterotypic models of osteosarcoma recapitulate tumor heterogeneity and biological behavior
  Milcah C. Scott, Hirotaka Tomiyasu, John R. Garbe, Ingrid Cornax, Clarissa Amaya, M Gerard O'Sullivan, Subbaya Subramanian, Brad A. Bryan, Jaime F. Modiano
  Disease Models & Mechanisms.2016;[Epub]     CrossRef
• Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment
  Hyo Min Jeong, Sun Wook Cho, Serk In Park
  Endocrinology and Metabolism.2016; 31(4): 485.     CrossRef

Genetic factors contribute for about 70% to 80% and environmental factors for about 20% to 30% to the pathogenesis of autoimmune thyroid disease (AITD). Relatives of AITD patients carry a risk to contract AITD themselves. The 5-year risk can be quantified by the so-called Thyroid Events Amsterdam-score, based on serum thyroid-stimulating hormone, thyroid peroxidase (TPO)-antibodies and family history. Subjects at risk may ask what they can do to prevent development of AITD. This review summarizes what is known about modulation of exposure to environmental factors in terms of AITD prevention. To stop smoking decreases the risk on Graves disease but increases the risk on Hashimoto disease. Moderate alcohol intake provides some protection against both Graves and Hashimoto disease. Low selenium intake is associated with a higher prevalence of thyroid autoimmunity, but evidence that selenium supplementation may lower TPO antibodies and prevent subclinical hypothyroidism remains inconclusive. Low serum vitamin D levels are associated with a higher prevalence of TPO antibodies, but intervention studies with extra vitamin D have not been done yet. Stress may provoke Graves hyperthyroidism but not Hashimoto thyroiditis. Estrogen use have been linked to a lower prevalence of Graves disease. The postpartum period is associated with an increased risk of AITD. Taking together, preventive interventions to diminish the risk of AITD are few, not always feasible, and probably of limited efficacy.

Citations

Citations to this article as recorded by  

• Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012
  Xiaowen Zhang, Yong Wang, Hongwei Wang, Xinlin Zhang
  The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e657.     CrossRef
• The role of medical and organizational measures in improving the quality of early detection and clinical examination of autoimmune thyroiditis among the population of the Republic of Belarus
  L. I. Danilova, V. A. Rozhko, I. V. Veyalkin, S. N. Nikanovich, T. M. Sharshakova
  Health and Ecology Issues.2024; 20(4): 129.     CrossRef
• Hyperthyroidism
  Layal Chaker, David S Cooper, John P Walsh, Robin P Peeters
  The Lancet.2024; 403(10428): 768.     CrossRef
• A Review of Thyroid Dysfunction Due to COVID-19
  Alireza Arefzadeh
  Mini-Reviews in Medicinal Chemistry.2024; 24(3): 265.     CrossRef
• Alteration in kynurenine pathway metabolites in young women with autoimmune thyroiditis
  Anna Krupa, Agnieszka Łebkowska, Marcin Kondraciuk, Karol Adam Kaminski, Irina Kowalska
  Scientific Reports.2024;[Epub]     CrossRef
• Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management
  Jin Wang, Ke Wan, Xin Chang, Rui-Feng Mao
  World Journal of Diabetes.2024; 15(3): 348.     CrossRef
• Assessment of Vitamin Concentrations in Patients with Hashimoto’s Thyroiditis and Their Relationships with Thyroid Function, Biochemical Status, and Anthropometric Parameters—A Preliminary Study
  Aniceta Ada Mikulska-Sauermann, Matylda Resztak, Marta Karaźniewicz-Łada, Dorota Filipowicz, Marek Ruchała, Franciszek K. Główka
  Nutrients.2024; 16(11): 1694.     CrossRef
• Toenail and blood selenium mediated regulation of thyroid dysfunction through immune cells: a mediation Mendelian randomization analysis
  Yu-jia Jiang, Yi-quan Xiong, Tao Huang, Yun-xiao Xiao
  Frontiers in Nutrition.2024;[Epub]     CrossRef
• The causal relationship between major depression disorder and thyroid diseases: A Mendelian randomization study and mediation analysis
  Xu Zhang, Qiao Lu, Yiping Luo, Luyao Wang, Yuan Tian, Xuemei Luo
  Journal of Affective Disorders.2024; 359: 287.     CrossRef
• The Role of miRNA in Hyperthyroidism Induced by Excessive Iodine in Drinking Water
  Zhihan Yang, Yishan Dong, Shuo Wang, Jing He, Zheng Shen, Jin Cheng, Jinyu Li, Qiaoling Liu, Ziqi Xu, Dianjun Sun, Wei Zhang
  Biological Trace Element Research.2024;[Epub]     CrossRef
• Causal effects of post-traumatic stress disorder on autoimmune thyroid disease: insights from mendelian randomization
  Zhaorong Chen, Yunfeng Yu, Jiayu Yao, Zirui Guo, Yanhui Cui, Fang Li, Changqi Li
  Frontiers in Psychiatry.2024;[Epub]     CrossRef
• Thyroid Autoimmunity is Associated with Dietary Fat Consumption
  Lulian Xu, Zhenzhen Liu, Xu Xu, Qiwen Wan, Juanying Zhen, Li Jiang, Bernard Man Yung Cheung, Chao Li
  The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
• Causal relationship between antihypertensive drugs and Hashimoto’s thyroiditis: a drug-target Mendelian randomization study
  Bing Cui, Aqin Chen, Chengcheng Xu, Chaoming Mao, Yuehua Chen
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Comparison of Thyroid Size-Specific Radioiodine Dose and New Modified Dose Calculation in the Treatment of Graves’ Disease
  Alisara Wongsuttilert, Ruchirek Thamcharoen, Yoswanich Maiprasert, Sathapakorn Siriwong
  Endocrinology and Metabolism.2024; 39(5): 758.     CrossRef
• Analysis of risk factors for autoimmune thyroid disease based on blood indicators and urinary iodine concentrations
  Jianning Liu, Zhuoying Feng, Ru Gao, Peng Liu, Fangang Meng, Lijun Fan, Lixiang Liu, Yang Du
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Genetic predisposition of MTHFR and TNFSF4 gene polymorphism related to hypothyroidism– A meta-analysis
  Iyshwarya Bhaskar Kalarani, Karpagavel Lakshmanan, Ramakrishnan Veerabathiran
  Gene Reports.2024; 37: 102091.     CrossRef
• Hashimoto’s thyroiditis and coexisting disorders in correlation with HLA status—an overview
  Peter Mikosch, Adrian Aistleitner, Markus Oehrlein, Eva Trifina-Mikosch
  Wiener Medizinische Wochenschrift.2023; 173(1-2): 41.     CrossRef
• The management and metabolic characterization: hyperthyroidism and hypothyroidism
  Yangyang Wang, YanPing Sun, Bingyou Yang, Qiuhong Wang, Haixue Kuang
  Neuropeptides.2023; 97: 102308.     CrossRef
• Zn and Se abrogate heavy metal mixture induced ovarian and thyroid oxido-inflammatory effects mediated by activation of NRF2-HMOX-1 in female albino rats
  Boma F. Eddie-Amadi, Anthonet N. Ezejiofor, Chinna N. Orish, Orish E. Orisakwe
  Current Research in Toxicology.2023; 4: 100098.     CrossRef
• Genetically predicted selenium concentrations and thyroid function: A two‐sample Mendelian randomization study
  Hui‐Jun Huang, Shan‐Shan Wang, Ming‐Min Jin, Bin‐Wei Cheng, Yu Liu, Xiao‐Chen Liu, Qiu‐Yan Yu, Xin‐Jun Yang
  Clinical Endocrinology.2023; 98(6): 813.     CrossRef
• Identification of Smoking‐Associated Transcriptome Aberration in Blood with Machine Learning Methods
  FeiMing Huang, QingLan Ma, JingXin Ren, JiaRui Li, Fen Wang, Tao Huang, Yu-Dong Cai, Bilal Alatas
  BioMed Research International.2023;[Epub]     CrossRef
• COVID-induced thyroid autoimmunity
  Alessandro Brancatella, Nicola Viola, Ferruccio Santini, Francesco Latrofa
  Best Practice & Research Clinical Endocrinology & Metabolism.2023; 37(2): 101742.     CrossRef
• Associations between vitamin D levels and dietary patterns in patients with Hashimoto’s thyroiditis
  Dean Kaličanin, Maja Cvek, Ana Barić, Veselin Škrabić, Ante Punda, Vesna Boraska Perica
  Frontiers in Nutrition.2023;[Epub]     CrossRef
• COMPARATIVE MORPHOLOGY OF THE THYROID GLAND
  L. O. Sviatotska
  Bulletin of Problems Biology and Medicine.2023; 1(2): 386.     CrossRef
• Evaluation and epigenetic impact of B12, vitamin D, folic acid and anemia in Hashimoto's thyroiditis: a clinical and molecular docking study
  Elif Sibel ASLAN, Savaş GÜR
  Journal of Health Sciences and Medicine.2023; 6(4): 705.     CrossRef
• Interactions between Polygenetic Variants and Lifestyle Factors in Hypothyroidism: A Hospital-Based Cohort Study
  Da Sol Kim, Sunmin Park
  Nutrients.2023; 15(17): 3850.     CrossRef
• Do Dietary Supplements Affect Inflammation, Oxidative Stress, and Antioxidant Status in Adults with Hypothyroidism or Hashimoto’s Disease?—A Systematic Review of Controlled Trials
  Katarzyna Kubiak, Maria Karolina Szmidt, Joanna Kaluza, Agnieszka Zylka, Ewa Sicinska
  Antioxidants.2023; 12(10): 1798.     CrossRef
• Identification and Preliminary Clinical Validation of Key Extracellular Proteins as the Potential Biomarkers in Hashimoto’s Thyroiditis by Comprehensive Analysis
  Zihan Xi, Tinglin Yang, Tao Huang, Jun Zhou, Peng Yang
  Biomedicines.2023; 11(12): 3127.     CrossRef
• An examination of retinal findings with optical coherence tomography in hypothyroidism patients with vitamin D deficiency: A comparative study
  Samet Sayılan, Dila Kırağı, Mehmet Tayfun Arslan
  Journal of Clinical Medicine of Kazakhstan.2023; 20(6): 36.     CrossRef
• The role of IL-4 −590 (C>T) Gene as diagnostic biomarker of Hashimoto thyroiditis disease patients in AL-Najaf provenance /Iraq
  Sarah Hasan Kadhum AL-Huchaimi, Mahdi Hussain AL-Ammar, Sabah N. AL-Fatlawi
  Al-Kufa University Journal for Biology.2023; 15(3): 14.     CrossRef
• Early life stress in women with autoimmune thyroid disorders
  Alessia Corso, Hermann Engel, Fabienne Müller, Serena Fiacco, Laura Mernone, Elena Gardini, Ulrike Ehlert, Susanne Fischer
  Scientific Reports.2023;[Epub]     CrossRef
• Protective Effects of Selenium and Zinc Against Nickel Chloride–Induced Hormonal Changes and Oxidative Damage in Thyroid of Pregnant Rats
  Imane Salah, Ounassa Adjroud, Awatef Elwej
  Biological Trace Element Research.2022; 200(5): 2183.     CrossRef
• Effects of animal protein intake during pregnancy on autoimmune thyroiditis in pregnant women with mild iodine deficiency
  Zhengyuan Wang, Jiaying Shen, Qi Song, Xueying Cui, Zehuan Shi, Jin Su, Jiajie Zang
  Journal of Human Nutrition and Dietetics.2022; 35(3): 542.     CrossRef
• Positive antithyroid antibody predicts severity of neuromyelitis optica spectrum disorder in children
  Liang Huo, Hua Wang, Yujun Yuan, Jian Gao, Xueyan Liu
  Multiple Sclerosis and Related Disorders.2022; 57: 103425.     CrossRef
• Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
  Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
  Endocrinología, Diabetes y Nutrición.2022; 69(10): 779.     CrossRef
• Are ethnic differences, urinary iodine status, lead and cadmium exposure associated with thyroid autoimmunity and hypothyroid status? A cross-sectional study
  Yi Chen, Qian Xiang, Ningjian Wang, Wen Zhang, Chunfang Zhu, Yuying Wang, Heng Wan, Jing Cheng, Kun Zhang, Yan Cai, Yingli Lu
  BMJ Open.2022; 12(2): e056909.     CrossRef
• The Association of Thyroid Nodules With Blood Trace Elements Identified in a Cross-Section Study
  Huixian Zeng, Yuanyuan Hu, Yaosheng Luo, Yanshi Ye, Cheng Song, Genfeng Yu, Zhi Chen, Siyang Liu, Yongqian Liang, Lingling Liu, Heng Wan, Jie Shen
  Frontiers in Nutrition.2022;[Epub]     CrossRef
• Nutritional Management of Thyroiditis of Hashimoto
  Yana Danailova, Tsvetelina Velikova, Georgi Nikolaev, Zorka Mitova, Alexander Shinkov, Hristo Gagov, Rossitza Konakchieva
  International Journal of Molecular Sciences.2022; 23(9): 5144.     CrossRef
• Association Between Vitamin D Deficiency and Autoimmune Thyroid Disorder: A Systematic Review
  Sabah A Khozam, Abdulhadi M Sumaili, Mohammed A Alflan, Rawan As'ad Salameh Shawabkeh
  Cureus.2022;[Epub]     CrossRef
• Metabolic Characteristics of Hashimoto’s Thyroiditis Patients and the Role of Microelements and Diet in the Disease Management—An Overview
  Aniceta A. Mikulska, Marta Karaźniewicz-Łada, Dorota Filipowicz, Marek Ruchała, Franciszek K. Główka
  International Journal of Molecular Sciences.2022; 23(12): 6580.     CrossRef
• Predictors of autoimmune thyroid disease
  Carol Cardona Attard, W. C. Candy Sze, Sandro Vella
  Baylor University Medical Center Proceedings.2022; 35(5): 608.     CrossRef
• Selenium Status and Supplementation Effects in Pregnancy—A Study on Mother–Child Pairs from a Single-Center Cohort
  Dorota Filipowicz, Ewelina Szczepanek-Parulska, Małgorzata Kłobus, Krzysztof Szymanowski, Thilo Samson Chillon, Sabrina Asaad, Qian Sun, Aniceta A. Mikulska-Sauermann, Marta Karaźniewicz-Łada, Franciszek K. Główka, Dominika Wietrzyk, Lutz Schomburg, Marek
  Nutrients.2022; 14(15): 3082.     CrossRef
• Inflammasome activation as a link between obesity and thyroid disorders: Implications for an integrated clinical management
  Rosario Le Moli, Veronica Vella, Dario Tumino, Tommaso Piticchio, Adriano Naselli, Antonino Belfiore, Francesco Frasca
  Frontiers in Endocrinology.2022;[Epub]     CrossRef
• Seasonality of month of birth in patients with autoimmune endocrine diseases: A systematic review
  Ana M. Ramos-Leví, Gloria Collado, Monica Marazuela
  Endocrinología, Diabetes y Nutrición (English ed.).2022; 69(10): 779.     CrossRef
• Impact of iodine intake on the pathogenesis of autoimmune thyroid disease in children and adults
  Iyshwarya Bhaskar Kalarani, Ramakrishnan Veerabathiran
  Annals of Pediatric Endocrinology & Metabolism.2022; 27(4): 256.     CrossRef
• Morphological features of thyroid benign focal neoplasms in Graves’ disease
  Yu.V. Buldygina, A.V. Zelinskaya, L.Yu. Zurnadzhy, Yu.M. Tarashchenko, S.L. Shlyakhtych, M.D. Tronko
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2022; 18(4): 213.     CrossRef
• Onset of Marine-Lenhart syndrome and Graves’ ophthalmopathy in a female patient treated with alemtuzumab for multiple sclerosis
  Rosario Le Moli, Marco Russo, Pasqualino Malandrino, Veronica Vella, Antonino Belfiore, Francesco Frasca
  Hormones.2021; 20(1): 161.     CrossRef
• Limited Genetic Overlap Between Overt Hashimoto’s Thyroiditis and Graves’ Disease in Twins: A Population-based Study
  Jakob Skov, Jan Calissendorff, Daniel Eriksson, Patrik Magnusson, Olle Kämpe, Sophie Bensing, Ralf Kuja-Halkola
  The Journal of Clinical Endocrinology & Metabolism.2021; 106(4): e1101.     CrossRef
• DNA Methylation Patterns in the HLA-DPB1 and PDCD1LG2 Gene Regions in Patients with Autoimmune Thyroiditis from Different Water Iodine Areas
  Siyuan Wan, Lixiang Liu, Bingxuan Ren, Mengying Qu, Huaiyong Wu, Wen Jiang, Xiaoming Wang, Hongmei Shen
  Thyroid.2021; 31(11): 1741.     CrossRef
• Персоналізація лікування хвороби Грейвса на підставі клініко- імунологічних характеристик перебігу захворювання
  Yu.V. Buldygina, S.L. Shlyakhtych, H.M. Terekhova, T.V. Fed’ko, V.M. Klochkova, L.S. Strafun, Z.H. Lysova, I.I. Savos’ko
  Endokrynologia.2021; 26(4): 409.     CrossRef
• Parity and Incidence of Thyroid Autoimmunity: A Population-Based Tehran Thyroid Study
  Miralireza Takyar, Maryam Rahmani, Atieh Amouzegar, Elham Madreseh, Maryam Tohidi, Ladan Mehran, Fereidoun Azizi
  Thyroid.2020; 30(8): 1186.     CrossRef
• Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review
  D. Gallo, L. Mortara, M. B. Gariboldi, S. A. M. Cattaneo, S. Rosetti, L. Gentile, D. M. Noonan, P. Premoli, C. Cusini, M. L. Tanda, L. Bartalena, E. Piantanida
  Journal of Endocrinological Investigation.2020; 43(4): 413.     CrossRef
• Hashimoto Thyreoiditis, therapeutische Optionen und extrathyreoidale Assoziationen – ein aktueller Überblick
  Eva Petnehazy, Wolfgang Buchinger
  Wiener Medizinische Wochenschrift.2020; 170(1-2): 26.     CrossRef
• Pathophysiological Role and Therapeutic Implications of Vitamin D in Autoimmunity: Focus on Chronic Autoimmune Diseases
  Mattia Bellan, Laura Andreoli, Chiara Mele, Pier Paolo Sainaghi, Cristina Rigamonti, Silvia Piantoni, Carla De Benedittis, Gianluca Aimaretti, Mario Pirisi, Paolo Marzullo
  Nutrients.2020; 12(3): 789.     CrossRef
• Thyroxine-binding globulin, peripheral deiodinase activity, and thyroid autoantibody status in association of phthalates and phenolic compounds with thyroid hormones in adult population
  Sohyeon Choi, Min Joo Kim, Young Joo Park, Sunmi Kim, Kyungho Choi, Gi Jeong Cheon, Yoon Hee Cho, Hye Li Jeon, Jiyoung Yoo, Jeongim Park
  Environment International.2020; 140: 105783.     CrossRef
• Immunomodulatory Effects of Vitamin D in Thyroid Diseases
  Chiara Mele, Marina Caputo, Alessandro Bisceglia, Maria Teresa Samà, Marco Zavattaro, Gianluca Aimaretti, Loredana Pagano, Flavia Prodam, Paolo Marzullo
  Nutrients.2020; 12(5): 1444.     CrossRef
• Significance of arsenic and lead in Hashimoto's thyroiditis demonstrated on thyroid tissue, blood, and urine samples
  Aleksandar Stojsavljević, Branislav Rovčanin, Jovana Jagodić, Danijela Drašković Radojković, Ivan Paunović, Marija Gavrović-Jankulović, Dragan Manojlović
  Environmental Research.2020; 186: 109538.     CrossRef
• Graves’ disease: Epidemiology, genetic and environmental risk factors and viruses
  Alessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, Sabrina Rosaria Paparo, Ilaria Ruffilli, Armando Patrizio, Claudia Giusti, Debora Gonnella, Alfonso Cristaudo, Rudy Foddis, Yehuda Shoenfeld, Poupak Fallahi
  Best Practice & Research Clinical Endocrinology & Metabolism.2020; 34(1): 101387.     CrossRef
• Vitamin D deficiency and thyroid autoantibody fluctuations in patients with Graves’ disease – A mere coincidence or a real relationship?
  Maria Teresa Płazińska, Agata Czarnywojtek, Nadia Sawicka-Gutaj, Małgorzata Zgorzalewicz-Stachowiak, Barbara Czarnocka, Paweł Gut, Maria Karlinska, Marta Fichna, Adam Stachowski, Marek Ruchała, Iwona Krela-Kaźmierczak, Leszek Królicki
  Advances in Medical Sciences.2020; 65(1): 39.     CrossRef
• An eight-year-old girl with autoimmune polyglandular syndrome type3A that developed during the course of primary Epstein–Barr virus (EBV) infection: clinical implication of EBV in autoimmune thyroid disease
  Shizuka Kirino, Hisae Nakatani, Aoi Honma, Asami Shinbo, Keiko Onda, Mari Okada, Masako Imai, Natsuko Suzuki, Akihiro Oshiba, Masayuki Nagasawa
  Immunological Medicine.2020; 43(1): 57.     CrossRef
• Exploring the role of copper and selenium in the maintenance of normal thyroid function among healthy Koreans
  Min Joo Kim, Soo Chin Kim, Soie Chung, Serim Kim, Ji Won Yoon, Young Joo Park
  Journal of Trace Elements in Medicine and Biology.2020; 61: 126558.     CrossRef
• A comparison of serum zinc levels in melasma and non-melasma patients: a preliminary study of thyroid dysfunction
  Indina Sastrini Sekarnesia, Irma Bernadette S. Sitohang, Triana Agustin, Wismandari Wisnu, Aida S. D. Hoemardani
  Acta Dermatovenerologica Alpina Pannonica et Adriatica.2020;[Epub]     CrossRef
• Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation
  Massimo Ralli, Diletta Angeletti, Marco Fiore, Vittorio D'Aguanno, Alessandro Lambiase, Marco Artico, Marco de Vincentiis, Antonio Greco
  Autoimmunity Reviews.2020; 19(10): 102649.     CrossRef
• Vitamin D and Autoimmune Thyroid Disease—Cause, Consequence, or a Vicious Cycle?
  Inês Henriques Vieira, Dírcea Rodrigues, Isabel Paiva
  Nutrients.2020; 12(9): 2791.     CrossRef
• New Insights into Mechanisms of Endocrine-Disrupting Chemicals in Thyroid Diseases: The Epigenetic Way
  Letizia Pitto, Francesca Gorini, Fabrizio Bianchi, Elena Guzzolino
  International Journal of Environmental Research and Public Health.2020; 17(21): 7787.     CrossRef
• Genotype association of IP6K3 gene with Hashimoto’s thyroiditis in Algerian population (Aures region)
  Warda Kherrour, Dean Kalicanin, Luka Brčić, Leila Hambaba, Mouloud Yahia, Souheyla Benbia, Vesna Boraska Perica
  Egyptian Journal of Medical Human Genetics.2020;[Epub]     CrossRef
• TOTAL ANTIOXIDANT ACTIVITY AND MANGANESE SUPEROXIDE DISMUTASE IN COMORBIDITY OF GASTROESOPHAGEAL REFLUX DISEASE AND AUTOIMMUNE THYROIDITIS IN STUDENT POPULATION
  Tamara M. Pasiieshvili, Natalia M. Zhelezniakova, Lyudmila M. Pasiyeshvili, Olga M. Kovalyova
  Wiadomości Lekarskie.2020; 73(12): 2644.     CrossRef
• Vitamin B12 and Vitamin D Levels in Patients with Autoimmune Hypothyroidism and Their Correlation with Anti-Thyroid Peroxidase Antibodies
  Hanife Şerife Aktaş
  Medical Principles and Practice.2020; 29(4): 364.     CrossRef
• Increased Risk of Thyroid Dysfunction Among Patients With Rheumatoid Arthritis
  Qian Li, Bin Wang, Kaida Mu, Jing Zhang, Yanping Yang, Wei Yao, Jie Zhu, Jin-an Zhang
  Frontiers in Endocrinology.2019;[Epub]     CrossRef
• Association between thyroglobulin polymorphisms and autoimmune thyroid disease: a systematic review and meta-analysis of case–control studies
  Ming-Liang Zhang, Dong-ming Zhang, Cai-E. Wang, Xiao-Long Chen, Fang-Zhou Liu, Jian-Xue Yang
  Genes & Immunity.2019; 20(6): 484.     CrossRef
• Changes in glucose‐lipid metabolism, insulin resistance, and inflammatory factors in patients with autoimmune thyroid disease
  Yi Lei, Jun Yang, Hua Li, Haihua Zhong, Qin Wan
  Journal of Clinical Laboratory Analysis.2019;[Epub]     CrossRef
• Evaluation of Qualitative Dietary Protocol (Diet4Hashi) Application in Dietary Counseling in Hashimoto Thyroiditis: Study Protocol of a Randomized Controlled Trial
  Natalia Wojtas, Lidia Wadolowska, Elżbieta Bandurska-Stankiewicz
  International Journal of Environmental Research and Public Health.2019; 16(23): 4841.     CrossRef
• Sjögren’s Syndrome and Autoimmune Thyroid Disease: Two Sides of the Same Coin
  Juan-Manuel Anaya, Paula Restrepo-Jiménez, Yhojan Rodríguez, Mónica Rodríguez-Jiménez, Yeny Acosta-Ampudia, Diana M. Monsalve, Yovana Pacheco, Carolina Ramírez-Santana, Nicolás Molano-González, Rubén D. Mantilla
  Clinical Reviews in Allergy & Immunology.2019; 56(3): 362.     CrossRef
• Disease Presentation and Remission Rate in Graves Disease Treated With Antithyroid Drugs: is Gender Really A Factor?
  Talia Diker-Cohen, Hadar Duskin-Bitan, Ilan Shimon, Dania Hirsch, Amit Akirov, Gloria Tsvetov, Eyal Robenshtok
  Endocrine Practice.2019; 25(1): 43.     CrossRef
• IRAK2 and TLR10 confer risk of Hashimoto’s disease: a genetic association study based on the Han Chinese population
  Miao Li, Wei Han, Li Zhu, Jue Jiang, Wei Qu, Lei Zhang, Liang Jia, Qi Zhou
  Journal of Human Genetics.2019; 64(7): 617.     CrossRef
• Environmental exposure to pesticides and risk of thyroid diseases
  Mar Requena, Antonia López-Villén, Antonio F. Hernández, Tesifón Parrón, Ángela Navarro, Raquel Alarcón
  Toxicology Letters.2019; 315: 55.     CrossRef
• Determining the Level of Knowledge about Graves’ Disease: Single-Center Results
  Hande Peynirci, Çiğdem Uzuntepe Aksu, Akif Doğan, Canan Ersoy
  Ankara Medical Journal.2019;[Epub]     CrossRef
• Association between lifestyle and thyroid dysfunction: a cross-sectional epidemiologic study in the She ethnic minority group of Fujian Province in China
  Yanling Huang, Liangchun Cai, Yuanyuan Zheng, Jinxing Pan, Liantao Li, Liyao Zong, Wei Lin, Jixing Liang, Huibin Huang, Junping Wen, Gang Chen
  BMC Endocrine Disorders.2019;[Epub]     CrossRef
• Vitamin D Receptor Gene Polymorphisms and Autoimmune Thyroiditis: Are They Associated with Disease Occurrence and Its Features?
  Adam Maciejewski, Michał J. Kowalczyk, Waldemar Herman, Adam Czyżyk, Marta Kowalska, Ryszard Żaba, Katarzyna Łącka
  BioMed Research International.2019; 2019: 1.     CrossRef
• Diagnosis of Graves’ disease – laboratory tests and possible difficulties in interpretation
  Agata Maria Kalicka
  Diagnostyka Laboratoryjna.2019; 55(2): 121.     CrossRef
• The influence of single-nucleotide polymorphisms of interleukin-1β -511 and +3954 on the susceptibility to Hashimoto’s thyroiditis in Egyptian women: immune-endocrine interactions
  Nearmeen M. Rashad, Manar H. Soliman, Mayada M. Mousa, Azza H. Abd El-Fatah
  The Egyptian Journal of Internal Medicine.2019; 31(1): 14.     CrossRef
• Global epidemiology of hyperthyroidism and hypothyroidism
  Peter N. Taylor, Diana Albrecht, Anna Scholz, Gala Gutierrez-Buey, John H. Lazarus, Colin M. Dayan, Onyebuchi E. Okosieme
  Nature Reviews Endocrinology.2018; 14(5): 301.     CrossRef
• Selenoproteins in human body: focus on thyroid pathophysiology
  Ana Valea, Carmen Emanuela Georgescu
  Hormones.2018; 17(2): 183.     CrossRef
• Epidemiology of hyperthyroidism in Iran: a systematic review and meta-analysis
  Sayed Mahmoud Sajjadi-Jazi, Farshad Sharifi, Mehdi Varmaghani, Hamidreza Aghaei Meybodi, Farshad Farzadfar, Bagher Larijani
  Journal of Diabetes & Metabolic Disorders.2018; 17(2): 345.     CrossRef
• The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis
  Su Wang, Yaping Wu, Zhihua Zuo, Yijing Zhao, Kun Wang
  Endocrine.2018; 59(3): 499.     CrossRef
• Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management
  Brigitte Decallonne, Emmanuel Bartholomé, Valérie Delvaux, Miguel D’haeseleer, Souraya El Sankari, Pierrette Seeldrayers, Bart Van Wijmeersch, Chantal Daumerie
  Acta Neurologica Belgica.2018; 118(2): 153.     CrossRef
• Synergistic interactions of Angiotensin Converting Enzyme (ACE) gene and Apolipoprotein E (APOE) gene polymorphisms with T1DM susceptibility in south India
  Padma-Malini Ravi, Rathika Chinniah, Ramgopal Sivanadham, Murali Vijayan, Dharmarajan Pannerselvam, S. Pushkala, Balakrishnan Karuppiah
  Meta Gene.2018; 18: 39.     CrossRef
• The effect of obesity and dietary habits on oxidative stress in Hashimoto’s thyroiditis
  Maria Giannakou, Katerina Saltiki, Emily Mantzou, Eleni Loukari, Georgios Philippou, Konstantinos Terzidis, Charalampos Stavrianos, Miltiades Kyprianou, Theodora Psaltopoulou, Kalliopi Karatzi, Maria Alevizaki
  Endocrine Connections.2018; 7(9): 990.     CrossRef
• Interaction of HLA-DRB1* alleles and CTLA4 (+ 49 AG) gene polymorphism in Autoimmune Thyroid Disease
  Sivanadham Ramgopal, Chinniah Rathika, Malini Ravi Padma, Vijayan Murali, Kannan Arun, Mohamed Nainar Kamaludeen, Karuppiah Balakrishnan
  Gene.2018; 642: 430.     CrossRef
• New insights into the etiopathogenesis of Hashimoto's Thyroiditis: The role of genetics and epigenetics
  Massimo Ralli, Armando De Virgilio, Marco Artico, Lucia Longo, Marco de Vincentiis, Antonio Greco
  Autoimmunity Reviews.2018; 17(10): 1065.     CrossRef
• Comorbidity of autoimmune thyroid disorders and psychiatric disorders during the postpartum period: a Danish nationwide register-based cohort study
  V. Bergink, V. J. M. Pop, P. R. Nielsen, E. Agerbo, T. Munk-Olsen, X. Liu
  Psychological Medicine.2018; 48(8): 1291.     CrossRef
• Spontaneous conversion from Graves’ disease to Hashimoto’s thyroiditis: a case report
  Muharrem Bayrak, Kenan Çadırcı, Emine Kartal Baykan, Ünsal Aydın, Ayşe Çarlıoğlu
  Ortadoğu Tıp Dergisi.2018; 10(1): 81.     CrossRef
• Association of established hypothyroidism-associated genetic variants with Hashimoto’s thyroiditis
  A. Barić, L. Brčić, S. Gračan, V. Torlak Lovrić, I. Gunjača, M. Šimunac, M. Brekalo, M. Boban, O. Polašek, M. Barbalić, T. Zemunik, A. Punda, V. Boraska Perica
  Journal of Endocrinological Investigation.2017; 40(10): 1061.     CrossRef
• Immune Response of Laying Hens Exposed to 30 ppm Ammonia for 25 Weeks
  H. Chen, F.F. Yan, J.Y. Hu, Yanan Wu, C.M. Tucker, A.R. Green, H.W. Cheng
  International Journal of Poultry Science.2017; 16(4): 139.     CrossRef
• Dietary Factors Associated with Plasma Thyroid Peroxidase and Thyroglobulin Antibodies
  Antonela Matana, Vesela Torlak, Dubravka Brdar, Marijana Popović, Bernarda Lozić, Maja Barbalić, Vesna Boraska Perica, Ante Punda, Ozren Polašek, Caroline Hayward, Tatijana Zemunik
  Nutrients.2017; 9(11): 1186.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept
  Barbara Altieri, Giovanna Muscogiuri, Luigi Barrea, Chantal Mathieu, Carla V. Vallone, Luca Mascitelli, Giorgia Bizzaro, Vincenzo M. Altieri, Giacomo Tirabassi, Giancarlo Balercia, Silvia Savastano, Nicola Bizzaro, Cristina L. Ronchi, Annamaria Colao, Alf
  Reviews in Endocrine and Metabolic Disorders.2017; 18(3): 335.     CrossRef
• A case‐control study of the association between ulcerative colitis and hyperthyroidism in an Asian population
  Ming‐Chieh Tsai, Herng‐Ching Lin, Cha‐Ze Lee
  Clinical Endocrinology.2017; 86(6): 825.     CrossRef
• Hashimoto's thyroiditis: relative recurrence risk ratio and implications for screening of first‐degree relatives
  Nikita Bothra, Nalini Shah, Manjunath Goroshi, Swati Jadhav, Sheetal Padalkar, Hemangini Thakkar, Gurudayal Singh Toteja, Vyankatesh Shivane, Anurag Lila, Tushar Bandgar
  Clinical Endocrinology.2017; 87(2): 201.     CrossRef
• Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature
  Dilia Giuggioli, M. Colaci, G. Cassone, P. Fallahi, F. Lumetti, A. Spinella, F. Campomori, A. Manfredi, C. U. Manzini, A. Antonelli, C. Ferri
  Clinical Rheumatology.2017; 36(3): 583.     CrossRef
• Are Perinatal Events Risk Factors for Childhood Thyroid Autoimmunity
  Berglind Jonsdottir, Markus Lundgren, Sara Wallengren, Åke Lernmark, Ida Jönsson, Helena Elding Larsson
  European Thyroid Journal.2017; 6(6): 298.     CrossRef
• Variants of Interleukin-22 Gene Confer Predisposition to Autoimmune Thyroid Disease
  Rong-hua Song, Qian Li, Wen Wang, Qiu-ming Yao, Xiao-qing Shao, Jin-an Zhang
  International Journal of Endocrinology.2017; 2017: 1.     CrossRef
• Environmental Issues in Thyroid Diseases
  Silvia Martina Ferrari, Poupak Fallahi, Alessandro Antonelli, Salvatore Benvenga
  Frontiers in Endocrinology.2017;[Epub]     CrossRef

Epidemiological data clearly show the existence of a strong inverse correlation between plasma high-density lipoprotein cholesterol (HDL-C) concentrations and the incidence of coronary heart disease. This relation is explained by a number of atheroprotective properties of HDL, first of all the ability to promote macrophage cholesterol transport. HDL are highly heterogeneous and are continuously remodeled in plasma thanks to the action of a number of proteins and enzymes. Among them, lecithin:cholesterol acyltransferase (LCAT) plays a crucial role, being the only enzyme able to esterify cholesterol within lipoproteins. LCAT is synthetized by the liver and it has been thought to play a major role in reverse cholesterol transport and in atheroprotection. However, data from animal studies, as well as human studies, have shown contradictory results. Increased LCAT concentrations are associated with increased HDL-C levels but not necessarily with atheroprotection. On the other side, decreased LCAT concentration and activity are associated with decreased HDL-C levels but not with increased atherosclerosis. These contradictory results confirm that HDL-C levels per se do not represent the functionality of the HDL system.

Citations

Citations to this article as recorded by  

• Association between Mycoplasma pneumoniae infection, high‑density lipoprotein metabolism and cardiovascular health (Review)
  Tao Shen, Yanfang Li, Tingting Liu, Yunzhi Lian, Luke Kong
  Biomedical Reports.2024;[Epub]     CrossRef
• Cholesterol transport and beyond: Illuminating the versatile functions of HDL apolipoproteins through structural insights and functional implications
  Aishwarya Sudam Bhale, Olivier Meilhac, Christian Lefebvre d'Hellencourt, Mookambeswaran A. Vijayalakshmi, Krishnan Venkataraman
  BioFactors.2024; 50(5): 922.     CrossRef
• Phytochemicals profiling of Cassia fistula fruit extract and its effect on serum lipids and hematological parameters in high‐fat diet‐induced hyperlipidemic female rats
  Maryam Tariq, Nazir Ahmad, Mahr Un Nisa, Muhammad Abdul Rahim, Eliasse Zongo
  Food Science & Nutrition.2024; 12(8): 5776.     CrossRef
• Lecithin-cholesterol acyltransferase and paraoxonase-1 levels in atherosclerotic cardiovascular disease patients in Nigeria
  Promise C. Nwaejigh, Maria O. Ebesunun, Oluwaseye M. Oladimeji
  African Journal of Laboratory Medicine.2024;[Epub]     CrossRef
• Low LCAT activity is linked to acute decompensated heart failure and mortality in patients with CKD
  Julia T. Stadler, Thomas Bärnthaler, Andrea Borenich, Insa E. Emrich, Hansjörg Habisch, Alankrita Rani, Michael Holzer, Tobias Madl, Gunnar H. Heine, Gunther Marsche
  Journal of Lipid Research.2024; 65(9): 100624.     CrossRef
• The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients
  Roxana Nartea, Brindusa Ilinca Mitoiu, Ioana Ghiorghiu
  Current Issues in Molecular Biology.2023; 45(4): 3146.     CrossRef
• Mannose-Coated Reconstituted Lipoprotein Nanoparticles for the Targeting of Tumor-Associated Macrophages: Optimization, Characterization, and In Vitro Evaluation of Effectiveness
  Akpedje S. Dossou, Morgan E. Mantsch, Ammar Kapic, William L. Burnett, Nirupama Sabnis, Jeffery L. Coffer, Rance E. Berg, Rafal Fudala, Andras G. Lacko
  Pharmaceutics.2023; 15(6): 1685.     CrossRef
• Abdominal obesity negatively influences key metrics of reverse cholesterol transport
  Jennifer Härdfeldt, Marica Cariello, Sara Simonelli, Alice Ossoli, Natasha Scialpi, Marilidia Piglionica, Emanuela Pasculli, Alessia Noia, Elsa Berardi, Patrizia Suppressa, Giuseppina Piazzolla, Carlo Sabbà, Laura Calabresi, Antonio Moschetta
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2022; 1867(2): 159087.     CrossRef
• Effects of Lactobacillus paracasei N1115 on dyslipidaemia: A randomized controlled study
  Hua Jiang, Shengjie Tan, Ke Ning, Hao Li, Wenzhi Zhao, Ai Zhao, Hong Zhu, Shijie Wang, Peiyu Wang, Yumei Zhang
  Journal of Functional Foods.2022; 89: 104956.     CrossRef
• LCAT- targeted therapies: Progress, failures and future
  Kaixu Yang, Junmin Wang, Hongjiao Xiang, Peilun Ding, Tao Wu, Guang Ji
  Biomedicine & Pharmacotherapy.2022; 147: 112677.     CrossRef
• Cyclodextrin boostered-high density lipoprotein for antiatherosclerosis by regulating cholesterol efflux and efferocytosis
  Yanyan Wang, Hai Gao, Xinya Huang, Zhaoan Chen, Pengyu Kang, Yunyi Zhou, Danhua Qin, Wenli Zhang, Jianping Liu
  Carbohydrate Polymers.2022; 292: 119632.     CrossRef
• Lipidomic Approaches to Study HDL Metabolism in Patients with Central Obesity Diagnosed with Metabolic Syndrome
  Gabriele Mocciaro, Simona D’Amore, Benjamin Jenkins, Richard Kay, Antonio Murgia, Luis Vicente Herrera-Marcos, Stefanie Neun, Alice P. Sowton, Zoe Hall, Susana Alejandra Palma-Duran, Giuseppe Palasciano, Frank Reimann, Andrew Murray, Patrizia Suppressa, C
  International Journal of Molecular Sciences.2022; 23(12): 6786.     CrossRef
• rHDL modeling and the anchoring mechanism of LCAT activation
  Tommaso Laurenzi, Chiara Parravicini, Luca Palazzolo, Uliano Guerrini, Elisabetta Gianazza, Laura Calabresi, Ivano Eberini
  Journal of Lipid Research.2021; 62: 100006.     CrossRef
• Vasculoprotective properties of plasma lipoproteins from brown bears (Ursus arctos)
  Matteo Pedrelli, Paolo Parini, Jonas Kindberg, Jon M. Arnemo, Ingemar Bjorkhem, Ulrika Aasa, Maria Westerståhl, Anna Walentinsson, Chiara Pavanello, Marta Turri, Laura Calabresi, Katariina Öörni, Gérman Camejo, Ole Fröbert, Eva Hurt-Camejo
  Journal of Lipid Research.2021; 62: 100065.     CrossRef
• The Fate of Dietary Cholesterol in the Kissing Bug Rhodnius prolixus
  Petter F. Entringer, David Majerowicz, Katia C. Gondim
  Frontiers in Physiology.2021;[Epub]     CrossRef
• Excesive consumption of unsaturated fatty acids leads to oxidative and inflammatory instability in Wistar rats
  Jelica D. Grujić-Milanović, Zoran Z. Miloradović, Nevena D. Mihailović-Stanojević, Vojislav V. Banjac, Strahinja Vidosavljević, Milan S. Ivanov, Danijela J. Karanović, Una-Jovana V. Vajić, Djurdjica M. Jovović
  Biomedicine & Pharmacotherapy.2021; 139: 111691.     CrossRef
• Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy
  Isabella Giacomini, Federico Gianfanti, Maria Andrea Desbats, Genny Orso, Massimiliano Berretta, Tommaso Prayer-Galetti, Eugenio Ragazzi, Veronica Cocetta
  Frontiers in Oncology.2021;[Epub]     CrossRef
• Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis
  Marco Zuin, Carlo Cervellati, Alessandro Trentini, Angelina Passaro, Valentina Rosta, Francesca Zimetti, Giovanni Zuliani
  Diagnostics.2021; 11(6): 984.     CrossRef
• Dapagliflozin reduces thrombin generation and platelet activation: implications for cardiovascular risk reduction in type 2 diabetes mellitus
  Christina Kohlmorgen, Stephen Gerfer, Kathrin Feldmann, Sören Twarock, Sonja Hartwig, Stefan Lehr, Meike Klier, Irena Krüger, Carolin Helten, Petra Keul, Sabine Kahl, Amin Polzin, Margitta Elvers, Ulrich Flögel, Malte Kelm, Bodo Levkau, Michael Roden, Jen
  Diabetologia.2021; 64(8): 1834.     CrossRef
• Impact of Dietary Lipids on the Reverse Cholesterol Transport: What We Learned from Animal Studies
  Bianca Papotti, Joan Carles Escolà-Gil, Josep Julve, Francesco Potì, Ilaria Zanotti
  Nutrients.2021; 13(8): 2643.     CrossRef
• Supramolecular copolymer modified statin-loaded discoidal rHDLs for atherosclerotic anti-inflammatory therapy by cholesterol efflux and M2 macrophage polarization
  Qiqi Zhang, Jianhua He, Fengfei Xu, Xinya Huang, Yanyan Wang, Wenli Zhang, Jianping Liu
  Biomaterials Science.2021; 9(18): 6153.     CrossRef
• Association between Small Dense Low-Density Lipoproteins and High-Density Phospolipid Content in Patients with Coronary Artery Disease with or without Diabetes
  Hanene Aoua, Ymène Nkaies, Ali Ben Khalfallah, Mohsen Sakly, Ezzedine Aouani, Nebil Attia
  Laboratory Medicine.2020; 51(3): 271.     CrossRef
• Biomechanical and biochemical investigation of erythrocytes in late stage human leptospirosis
  J.A.X. Silva, A.V.P. Albertini, C.S.M. Fonseca, D.C.N. Silva, V.C.O. Carvalho, V.L.M. Lima, A. Fontes, E.V.L. Costa, R.A. Nogueira
  Brazilian Journal of Medical and Biological Research.2020;[Epub]     CrossRef
• Cardioprotective Properties of HDL: Structural and Functional Considerations
  Eleni Pappa, Moses S. Elisaf, Christina Kostara, Eleni Bairaktari, Vasilis K. Tsimihodimos
  Current Medicinal Chemistry.2020; 27(18): 2964.     CrossRef
• Relationship between non–high-density lipoprotein cholesterol/apolipoprotein A-I and monocyte/high-density lipoprotein cholesterol ratio and coronary heart disease
  Ya Li, Shu Li, Yulin Ma, Jialing Li, Mingying Lin, Jing Wan
  Coronary Artery Disease.2020; 31(7): 623.     CrossRef
• Lipid transfer to high‐density lipoproteins in coronary artery disease patients with and without previous cerebrovascular ischemic events
  Carlos J.D.G. Barbosa, Raul C. Maranhão, Renata S. Barreiros, Fatima R. Freitas, André Franci, Célia M.C. Strunz, Flávia B.B. Arantes, Thauany M. Tavoni, José A.F. Ramires, Roberto Kalil Filho, José C. Nicolau
  Clinical Cardiology.2019; 42(11): 1100.     CrossRef
• Antibodies Against the C-Terminus of ApoA-1 Are Inversely Associated with Cholesterol Efflux Capacity and HDL Metabolism in Subjects with and without Type 2 Diabetes Mellitus
  Robin P. F. Dullaart, Sabrina Pagano, Frank G. Perton, Nicolas Vuilleumier
  International Journal of Molecular Sciences.2019; 20(3): 732.     CrossRef
• The effect of chronic kidney disease on lipid metabolism
  Neris Dincer, Tuncay Dagel, Baris Afsar, Adrian Covic, Alberto Ortiz, Mehmet Kanbay
  International Urology and Nephrology.2019; 51(2): 265.     CrossRef
• Biological Consequences of Dysfunctional HDL
  Angela Pirillo, Alberico Luigi Catapano, Giuseppe Danilo Norata
  Current Medicinal Chemistry.2019; 26(9): 1644.     CrossRef
• Plasma lecithin:cholesterol acyltransferase and phospholipid transfer protein activity independently associate with nonalcoholic fatty liver disease
  Karlijn J. Nass, Eline H. van den Berg, Eke G. Gruppen, Robin P. F. Dullaart
  European Journal of Clinical Investigation.2018;[Epub]     CrossRef
• An integrated metabolomic strategy for the characterization of the effects of Chinese yam and its three active components on septic cardiomyopathy
  Ning Zhou, Meng-Nan Zeng, Kai Li, Yan-Yun Yang, Zhi-Yao Bai, Xiao-Ke Zheng, Wei-Sheng Feng
  Food & Function.2018; 9(9): 4989.     CrossRef
• Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia
  Kyong Yeun Jung, Kyoung Min Kim, Sun Kyoung Han, Han Mi Yun, Tae Jung Oh, Sung Hee Choi, Kyong Soo Park, Hak Chul Jang, Soo Lim
  Circulation Journal.2018; 82(5): 1387.     CrossRef
• Association Between Serum LDL-C and ApoB and SYNTAX Score in Patients With Stable Coronary Artery Disease
  Taiwu Lin, Luzhao Wang, Jingbin Guo, Peng Liu, Liheng Chen, Mengqiu Wei, Gongxin Li
  Angiology.2018; 69(8): 724.     CrossRef
• Influence of i.v. lipid emulsion on lipoprotein subclass in preterm infants
  Hiroki Suganuma, Naho Ikeda, Natsuki Ohkawa, Hiromichi Shoji, Toshiaki Shimizu
  Pediatrics International.2018; 60(9): 839.     CrossRef
• The HDL cholesterol/apolipoprotein A-I ratio: an indicator of cardiovascular disease
  Eun-Jung Rhee, Christopher D. Byrne, Ki-Chul Sung
  Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(2): 148.     CrossRef
• Moringa Leaves Prevent Hepatic Lipid Accumulation and Inflammation in Guinea Pigs by Reducing the Expression of Genes Involved in Lipid Metabolism
  Manal Almatrafi, Marcela Vergara-Jimenez, Ana Murillo, Gregory Norris, Christopher Blesso, Maria Fernandez
  International Journal of Molecular Sciences.2017; 18(7): 1330.     CrossRef

Diabetes is an increasing epidemic in Korea, and associated diabetic peripheral neuropathy (DPN) is its most common and disabling complication. DPN has an insidious onset and heterogeneous clinical manifestations, making it difficult to detect high-risk patients of DPN. Early diagnosis is recommended and is the key factor for a better prognosis and preventing diabetic foot ulcers, amputation, or disability. However, diagnostic tests for DPN are not clearly established because of the various pathophysiology developing from the nerve injury to clinical manifestations, differences in mechanisms according to the type of diabetes, comorbidities, and the unclear natural history of DPN. Therefore, DPN remains a challenge for physicians to screen, diagnose, follow up, and evaluate for treatment response. In this review, diagnosing DPN using various methods to assess clinical symptoms and/or signs, sensorineural impairment, and nerve conduction studies will be discussed. Clinicians should rely on established modalities and utilize current available testing as complementary to specific clinical situations.

Citations

Citations to this article as recorded by  

• The Relationship Between UA/HDL and Diabetic Peripheral Neuropathy: A Cross-Sectional Analysis
  Ruoxi Zhen, Shuqi Wang, Shuchun Chen
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 969.     CrossRef
• Role of Regenerative Therapeutics in Diabetic Peripheral Neuropathy: Current Advances and Future Prospects
  Sanjay Sharma, Ravi Velamoor Rangarajan
  European Journal of Medical and Health Sciences.2024; 6(2): 1.     CrossRef
• Understanding the Clinical Relationship Between Diabetic Retinopathy, Nephropathy, and Neuropathy: A Comprehensive Review
  Aditi Kulkarni, Archana R Thool, Sachin Daigavane
  Cureus.2024;[Epub]     CrossRef
• Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach
  Aysegul Atmaca, Aysegul Ketenci, Ibrahim Sahin, Ihsan Sukru Sengun, Ramazan Ilyas Oner, Hacer Erdem Tilki, Mine Adas, Hatice Soyleli, Tevfik Demir
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Predicting the efficacy of rehabilitation in patients with type 2 diabetes and diabetic polyneuropathy
  T.H. Bakaliuk, N.R. Makarchuk, H.O. Stelmakh, V.I. Pankiv, I.I. Kamyshna
  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(3): 155.     CrossRef
• Nail-fold capillaroscopy as a rapid non-invasive tool for assessment of microvascular complications in diabetes mellitus: A cross-sectional study
  Prakhar Srivastava, Niti Khunger, R. K. Duvesh, Shikha Bansal, Prachi Srivastava
  Journal of Onychology and Nail Surgery.2024; 1: 4.     CrossRef
• DSPNet: A Self-ONN Model for Robust DSPN Diagnosis From Temperature Maps
  Amith Khandakar, Muhammad E. H. Chowdhury, Mamun Bin Ibne Reaz, Serkan Kiranyaz, Anwarul Hasan, Tawsifur Rahman, Sawal Hamid Md. Ali, Mohd Ibrahim bin Shapiai @ Abd. Razak, Ahmad Ashrif A. Bakar, Kanchon Kanti Podder, Moajjem Hossain Chowdhury, Md. Ahasan
  IEEE Sensors Journal.2023; 23(5): 5370.     CrossRef
• A Machine Learning-Based Severity Prediction Tool for the Michigan Neuropathy Screening Instrument
  Fahmida Haque, Mamun B. I. Reaz, Muhammad E. H. Chowdhury, Mohd Ibrahim bin Shapiai, Rayaz A. Malik, Mohammed Alhatou, Syoji Kobashi, Iffat Ara, Sawal H. M. Ali, Ahmad A. A. Bakar, Mohammad Arif Sobhan Bhuiyan
  Diagnostics.2023; 13(2): 264.     CrossRef
• Screening for diabetic peripheral neuropathy in resource-limited settings
  Ken Munene Nkonge, Dennis Karani Nkonge, Teresa Njeri Nkonge
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Assessment of Lumbosacral Nerve Roots in Patients with Type 2 Diabetic Peripheral Neuropathy Using Diffusion Tensor Imaging
  He Chen, Yanyan Xu, Wei Wang, Ruifen Deng, Zhaoqing Li, Sheng Xie, Jinsong Jiao
  Brain Sciences.2023; 13(5): 828.     CrossRef
• Evidence of impaired H-reflex and H-reflex rate-dependent depression in diabetes, prediabetes and obesity: a mini-review
  Rebeca Kababie-Ameo, Gabriela Gutiérrez-Salmeán, Carlos A. Cuellar
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• The effect of polyneuropathy severity on nerve conduction and pain syndrome in patients with type 2 diabetes
  A.Ya. Sabovchyk, M.M. Oros
  INTERNATIONAL NEUROLOGICAL JOURNAL.2023; 19(6): 161.     CrossRef
• Effects of Neural Mobilization in Diabetic Peripheral Neuropathy: A Scoping Review
  Muhammad Azharuddin, Sarah Parveen, Majumi M. Noohu
  Journal of Chiropractic Medicine.2023; 22(4): 313.     CrossRef
• Effect of massage, passive neural mobilization and transcutaneous electrical nerve stimulation on magnetic resonance diffusion tensor imaging (MR-DTI) of the tibial nerve in a patient with type 2 diabetes mellitus induced neuropathy: a case report
  Goyal Manu, Mittal Amit, Samuel Asir John
  Physiotherapy Theory and Practice.2022; 38(13): 3273.     CrossRef
• Diabetic corneal neuropathy as a surrogate marker for diabetic peripheral neuropathy
  WeiZheng So, NatalieShi Qi Wong, HongChang Tan, MollyTzu Yu Lin, IsabelleXin Yu Lee, JodhbirS Mehta, Yu-Chi Liu
  Neural Regeneration Research.2022; 17(10): 2172.     CrossRef
• SUDOSCAN in Combination with the Michigan Neuropathy Screening Instrument Is an Effective Tool for Screening Diabetic Peripheral Neuropathy
  Tae Jung Oh, Yoojung Song, Hak Chul Jang, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(2): 319.     CrossRef
• Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification Using Nerve Conduction Studies
  Fahmida Haque, Mamun B. I. Reaz, Muhammad E. H. Chowdhury, Serkan Kiranyaz, Sawal H. M. Ali, Mohammed Alhatou, Rumana Habib, Ahmad A. A. Bakar, Norhana Arsad, Geetika Srivastava, Paolo Crippa
  Computational Intelligence and Neuroscience.2022; 2022: 1.     CrossRef
• The Presence of Clonal Hematopoiesis Is Negatively Associated with Diabetic Peripheral Neuropathy in Type 2 Diabetes
  Tae Jung Oh, Han Song, Youngil Koh, Sung Hee Choi
  Endocrinology and Metabolism.2022; 37(2): 243.     CrossRef
• Advances in traditional Chinese medicine as adjuvant therapy for diabetic foot
  Fa-Shun Liu, Yue Li, Xian-Shan Guo, Rui-Chen Liu, Hong-Ya Zhang, Zhen Li
  World Journal of Diabetes.2022; 13(10): 851.     CrossRef
• Magnitude of diabetic peripheral neuropathy in Saudi Arabia: a systematic review and meta-analysis
  Lukman Femi Owolabi, Mushabab Alghamdi, Bappa Adamu, Magaji Garba Taura, Abubakar Jibo, Mohammed Almansour, Saeed Naseer Alaklabi, Mohammed Ali Alghamdi, Yousef Ayesh Alotaibi, Isa Adamu Imam, Reda Abdelrazak, Ahmad Rafaat, Muktar Hassan Aliyu
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Artificial Intelligence Methodologies Applied to Technologies for Screening, Diagnosis and Care of the Diabetic Foot: A Narrative Review
  Gaetano Chemello, Benedetta Salvatori, Micaela Morettini, Andrea Tura
  Biosensors.2022; 12(11): 985.     CrossRef
• Diabetic foot ulcer: Challenges and future
  Li Yang, Gui-Chuan Rong, Qi-Nan Wu
  World Journal of Diabetes.2022; 13(12): 1014.     CrossRef
• A review of the current evidence on the sensitivity and specificity of the Ipswich touch test for the screening of loss of protective sensation in patients with diabetes mellitus
  Arnold Hu, Beatrice Koh, Melissa- Raye Teo
  Diabetology International.2021; 12(2): 145.     CrossRef
• Prevalence of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus at a tertiary referral centre in Singapore
  Arnold Hu Hanquan, Melissa-Raye Teo Li Wen
  Proceedings of Singapore Healthcare.2021; 30(4): 265.     CrossRef
• Performance Analysis of Conventional Machine Learning Algorithms for Diabetic Sensorimotor Polyneuropathy Severity Classification
  Fahmida Haque, Mamun Bin Ibne Reaz, Muhammad Enamul Hoque Chowdhury, Geetika Srivastava, Sawal Hamid Md Ali, Ahmad Ashrif A. Bakar, Mohammad Arif Sobhan Bhuiyan
  Diagnostics.2021; 11(5): 801.     CrossRef
• Thai version of the Questionnaire for Diabetes-Related Foot Disease (Thai Q-DFD): validity and reliability
  Rapeepun Thungtak, Jirabhorn Wannapakhe, Saitida Lapanantasin
  Heliyon.2021; 7(8): e07832.     CrossRef
• A nomogram-based diabetic sensorimotor polyneuropathy severity prediction using Michigan neuropathy screening instrumentations
  Fahmida Haque, Mamun Bin Ibne Reaz, Muhammad E.H. Chowdhury, Sawal Hamid Md Ali, Ahmad Ashrif A Bakar, Tawsifur Rahman, Syoji Kobashi, Chitra A. Dhawale, Mohammad Arif Sobhan Bhuiyan
  Computers in Biology and Medicine.2021; 139: 104954.     CrossRef
• Correlation Between Hemoglobin Glycosylation Index and Nerve Conduction Velocity in Patients with Type 2 Diabetes Mellitus
  Zelin Li, Yuan Gao, Yujiao Jia, Shuchun Chen
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2021; Volume 14: 4757.     CrossRef
• Liver fibrosis indices are related to diabetic peripheral neuropathy in individuals with type 2 diabetes
  Kyuho Kim, Tae Jung Oh, Hyen Chung Cho, Yun Kyung Lee, Chang Ho Ahn, Bo Kyung Koo, Jae Hoon Moon, Sung Hee Choi, Hak Chul Jang
  Scientific Reports.2021;[Epub]     CrossRef
• Standard Clinical Screening Tests, Sural Radial Amplitude Ratio and F Wave Latency Compared to Conventional Nerve Conduction Studies in the Assessment of Sensorimotor Polyneuropathy in Patients with Type 2 Diabetes Mellitus
  Saraswathi Ramanathan, Raji Thomas, Asem Rangita Chanu, Dukhabandu Naik, Felix Jebasingh, Ajit Sivadasan, Nihal Thomas
  Indian Journal of Endocrinology and Metabolism.2021; 25(6): 509.     CrossRef
• IFN‐γ/mTORC1 decreased Rab11 in Schwann cells of diabetic peripheral neuropathy, inhibiting cell proliferation via GLUT1 downregulation
  Wei Du, Song Zhao, Fan Gao, Mengyu Wei, Jiahui An, Keqi Jia, Fan Li, Lin Zhu, Jun Hao
  Journal of Cellular Physiology.2020; 235(7-8): 5764.     CrossRef
• Diagnosis and treatment of the early stages of diabetic polyneuropathy
  V. N. Khramilin, A. N. Zavyalov, I. Yu. Demidova
  Meditsinskiy sovet = Medical Council.2020; (7): 56.     CrossRef
• Diabetic Peripheral Neuropathy: Is it Underdiagnosed?
  Rizaldy T. Pinzon, M. Kes, Rosa De Lima R. Sa
  Asian Journal of Biological Sciences.2020; 13(2): 168.     CrossRef
• The Effects of Tocotrienol-Rich Vitamin E (Tocovid) on Diabetic Neuropathy: A Phase II Randomized Controlled Trial
  Yeek Tat Ng, Sonia Chew Wen Phang, Gerald Chen Jie Tan, En Yng Ng, Nevein Philip Botross Henien, Uma Devi M. Palanisamy, Badariah Ahmad, Khalid Abdul Kadir
  Nutrients.2020; 12(5): 1522.     CrossRef
• Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis
  Wondimeneh Shibabaw Shiferaw, Tadesse Yirga Akalu, Yeshamble Work, Yared Asmare Aynalem
  BMC Endocrine Disorders.2020;[Epub]     CrossRef
• Choosing a Vibratory Test to Pair With Semmes Weinstein Monofilament Testing for Evaluating Lower Extremity Sensation in Patients With Diabetes: A Comparison of Three Vibratory Methodologies
  Bryan Raymond, James Steriovski, KaNesha Gillyard, Chalen Yang, Stephanie C. Wu, Ryan T. Crews
  Journal of Diabetes Science and Technology.2020; 14(1): 8.     CrossRef
• Is it possible to substitute the monofilament test for the Ipswich Touch Test in screening for peripheral diabetic neuropathy?
  Luz Marina Alfonso Dutra, Mirian Conceição Moura, Flaviene Alves do Prado, Giselle De Oliveira Lima, Manuela Costa Melo, Rubens Nelson Morato Fernandez, Maria Rita Carvalho Garbi Novaes
  Diabetology & Metabolic Syndrome.2020;[Epub]     CrossRef
• Correlation Between Thioredoxin-Interacting Protein and Nerve Conduction Velocity in Patients With Type 2 Diabetes Mellitus
  Yuan Gao, Shuchun Chen, Minmin Peng, Zi Wang, Luping Ren, Shumin Mu, Meiling Zheng
  Frontiers in Neurology.2020;[Epub]     CrossRef
• Performance analysis of noninvasive electrophysiological methods for the assessment of diabetic sensorimotor polyneuropathy in clinical research: a systematic review and meta-analysis with trial sequential analysis
  Fahmida Haque, Mamun Bin Ibne Reaz, Sawal Hamid Md Ali, Norhana Arsad, Muhammad Enamul Hoque Chowdhury
  Scientific Reports.2020;[Epub]     CrossRef
• The impact of demographic and clinical characteristics on diabetic painful neuropathy
  António Assunção, Dina Campos, Rui Marques, Inês Cunha, Patrícia Santos, Adriana Martins, Ana Sofia Gonçalves, Ana Rebelo, Carolina Lima, César Matos, Ana Cristina Prata, José Tiago Teixeira, Luís Duarte, Mariana Belo, Patrícia Figueiredo, Tiago Letras Ro
  Romanian Journal of Internal Medicine.2020; 58(1): 13.     CrossRef
• Nanotechnology in peripheral nerve repair and reconstruction
  Cristiana R. Carvalho, Joana Silva-Correia, Joaquim M. Oliveira, Rui L. Reis
  Advanced Drug Delivery Reviews.2019; 148: 308.     CrossRef
• The risk factors for diabetic peripheral neuropathy: A meta-analysis
  Xiuxiu Liu, Yuyan Xu, Miaomiao An, Qibing Zeng, Antonio Palazón-Bru
  PLOS ONE.2019; 14(2): e0212574.     CrossRef
• Association between deterioration in muscle strength and peripheral neuropathy in people with diabetes
  Tae Jung Oh, Sunyoung Kang, Jie-Eun Lee, Jae Hoon Moon, Sung Hee Choi, Soo Lim, Hak Chul Jang
  Journal of Diabetes and its Complications.2019; 33(8): 598.     CrossRef
• Characterizing distal peripheral neuropathy in type 2 diabetes mellitus in a semi-urban community setting in Peru
  Meera F Iyengar, Antonio Bernabe-Ortiz
  Journal of Global Health Reports.2019;[Epub]     CrossRef
• A study protocol on nerve mobilization induced diffusion tensor imaging values in posterior tibial nerve in healthy controls and in patients with diabetic neuropathy-multigroup pretest posttest design
  Manu Goyal, Vandana Esht, Amit Mittal
  Contemporary Clinical Trials Communications.2019; 16: 100451.     CrossRef
• The Akt/mTOR cascade mediates high glucose-induced reductions in BDNF via DNMT1 in Schwann cells in diabetic peripheral neuropathy
  Cui-Hong Zhang, Xin Lv, Wei Du, Mei-Juan Cheng, Ya-Ping Liu, Lin Zhu, Jun Hao
  Experimental Cell Research.2019; 383(1): 111502.     CrossRef
• Transcriptome analysis of dorsal root ganglia's diabetic neuropathy reveals mechanisms involved in pain and regeneration
  Maria Carolina Pedro Athie, Andre Schwambach Vieira, Juliana Maia Teixeira, Gilson Gonçalves dos Santos, Elayne Vieira Dias, Claudia Herrera Tambeli, Cesar Renato Sartori, Carlos A. Parada
  Life Sciences.2018; 205: 54.     CrossRef
• Diagnosis and Management of Diabetic Peripheral Neuropathy
  Seong-Su Moon
  The Journal of Korean Diabetes.2018; 19(3): 153.     CrossRef
• Efficacy of epalrestat plus α-lipoic acid combination therapy versus monotherapy in patients with diabetic peripheral neuropathy: a meta-analysis of 20 randomized controlled trials
  Ming Zhao, Jia-Yi Chen, Yu-Dong Chu, Ya-Bin Zhu, Lin Luo, Shi-Zhong Bu
  Neural Regeneration Research.2018; 13(6): 1087.     CrossRef
• Interactions between and Shared Molecular Mechanisms of Diabetic Peripheral Neuropathy and Obstructive Sleep Apnea in Type 2 Diabetes Patients
  Hong Shen, Junrong Zhao, Ying Liu, Guangdong Sun
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Evaluation of the healthy median nerve elasticity
  Bihui Zhu, Feng Yan, Ying He, Liyun Wang, Xi Xiang, Yuanjiao Tang, Yujia Yang, Li Qiu
  Medicine.2018; 97(43): e12956.     CrossRef
• Association between thermal threshold abnormalities and peripheral artery disease in patients with type 2 diabetes
  Yi-Jing Sheen, Tsai-Chung Li, Jiann-Liang Lin, Wen-Chen Tsai, Chuen-Der Kao, Cho-Tsan Bau, Wayne H.-H. Sheu
  Medicine.2018; 97(51): e13803.     CrossRef
• Neurogenic Pain Disorder in the Foot and Ankle: Peripheral Neuropathy
  Hak Jun Kim, Young Hwan Park, Soo Hyun Kim
  Journal of the Korean Orthopaedic Association.2017; 52(4): 305.     CrossRef
• Diabetes-Related Microvascular Complications: What Every Nurse Practitioner Needs to Know
  Eileen Egan
  The Journal for Nurse Practitioners.2017; 13(3): 192.     CrossRef
• Comparison of electrochemical skin conductance and vibration perception threshold measurement in the detection of early diabetic neuropathy
  Amit Goel, Channabasappa Shivaprasad, Anish Kolly, Vijaya Sarathi H. A., Sridevi Atluri, Rayaz Ahmed Malik
  PLOS ONE.2017; 12(9): e0183973.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Nailfold capillary abnormalities are associated with type 2 diabetes progression and correlated with peripheral neuropathy
  Po-Chi Hsu, Pei-Yung Liao, Hen-Hong Chang, John Y. Chiang, Yu-Chuen Huang, Lun-Chien Lo
  Medicine.2016; 95(52): e5714.     CrossRef

Diabetes is a well-known risk factor of cardiovascular morbidity and mortality, and the beneficial effect of improved glycemic control on cardiovascular complications has been well established. However, the rosiglitazone experience aroused awareness of potential cardiovascular risk associated with diabetes drugs and prompted the U.S. Food and Drug Administration to issue new guidelines about cardiovascular risk. Through postmarketing cardiovascular safety trials, some drugs demonstrated cardiovascular benefits, while some antidiabetic drugs raised concern about a possible increased cardiovascular risk associated with drug use. With the development of new classes of drugs, treatment options became wider and the complexity of glycemic management in type 2 diabetes has increased. When choosing the appropriate treatment strategy for patients with type 2 diabetes at high cardiovascular risk, not only the glucose-lowering effects, but also overall benefits and risks for cardiovascular disease should be taken into consideration.

Citations

Citations to this article as recorded by  

• Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study
  Kyoung Jin Kim, Jimi Choi, Juneyoung Lee, Jae Hyun Bae, Jee Hyun An, Hee Young Kim, Hye Jin Yoo, Ji A. Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Sin Gon Kim, Nam Hoon Kim
  Cardiovascular Diabetology.2019;[Epub]     CrossRef
• Sodium‐glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter‐organ crosstalk
  Jin Hee Kim, Minyoung Lee, Soo Hyun Kim, So Ra Kim, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Jin Won Cho, Yong‐ho Lee
  Diabetes, Obesity and Metabolism.2019; 21(4): 801.     CrossRef
• Glitazones and alpha-glucosidase inhibitors as the second-line oral anti-diabetic agents added to metformin reduce cardiovascular risk in Type 2 diabetes patients: a nationwide cohort observational study
  Cheng-Wei Chan, Chu-Leng Yu, Jiunn-Cherng Lin, Yu-Cheng Hsieh, Che-Chen Lin, Chen-Ying Hung, Cheng-Hung Li, Ying-Chieh Liao, Chu-Pin Lo, Jin-Long Huang, Ching-Heng Lin, Tsu-Juey Wu
  Cardiovascular Diabetology.2018;[Epub]     CrossRef
• Normoglucemiantes orales y riesgo cardiovascular
  Guillermo Guzmán, Juan Esteban Gómez, Leidy Johanna Plaza, María Claudia Sánchez
  Revista Colombiana de Cardiología.2018; 25(5): 333.     CrossRef
• Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study
  N.H. Kim, J. Choi, N.H. Kim, K.M. Choi, S.H. Baik, J. Lee, S.G. Kim
  Diabetes & Metabolism.2018; 44(4): 361.     CrossRef
• Obesity and Type 2 Diabetes in Our Youth: A Recipe for Cardiovascular Disease
  Angela Kaye Wooton, Lynne M. Melchior
  The Journal for Nurse Practitioners.2017; 13(3): 222.     CrossRef
• Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes
  Ilaria Campesi, Flavia Franconi, Giuseppe Seghieri, Marco Meloni
  Pharmacological Research.2017; 119: 195.     CrossRef
• The Landscape of Glucose-Lowering Therapy and Cardiovascular Outcomes: From Barren Land to Metropolis
  Mona P. Nasrallah, Charbel Abi Khalil, Marwan M. Refaat
  BioMed Research International.2017; 2017: 1.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef

Diabetes is often associated with chronic kidney disease (CKD) and is the primary cause of kidney failure in half of patients who receive dialysis therapy. Given the increasing prevalence of diabetes and its high morbidity and mortality, diabetic nephropathy is a serious drawback in individual patients and a tremendous socioeconomic burden on society. Despite growing concern for the management of diabetic nephropathy, the prevalence of CKD with diabetes is the same today as it was 20 years ago. The current strategy to manage diabetic nephropathy, including the control of hyperglycemia, dyslipidemia, and blood pressure and the wide-spread use of renin-angiotensin-aldosterone system inhibitors, is well established to be beneficial in the early stages of diabetic nephropathy. However, the effects are uncertain in patients with relatively progressed CKD. Therefore, early diagnosis or risk verification is extremely important in order to reduce the individual and socioeconomic burdens associated with diabetic nephropathy by providing appropriate management to prevent the development and progression of this condition. This review focuses on recent research and guidelines regarding risk assessment, advances in medical treatment, and challenges of and future treatments for diabetic nephropathy.

Citations

Citations to this article as recorded by  

• The Role of Angiotensin-Converting Enzyme (ACE) Polymorphisms in the Risk of Development and Treatment of Diabetic Nephropathy
  Magdalena Król-Kulikowska, Nikita Abramenko, Milan Jakubek, Mirosław Banasik, Marta Kepinska
  Journal of Clinical Medicine.2024; 13(4): 995.     CrossRef
• Diagnostic utility of renal shear wave elastography and renal Doppler findings in diabetic nephropathy: a case–control study
  Ahmed Abdelrahman Baz, Eman Muhammad Abdeen, Mona Yousry Helmy, Abo El-Magd Al-Bohy
  Egyptian Journal of Radiology and Nuclear Medicine.2024;[Epub]     CrossRef
• Schisandrin A Attenuates Diabetic Nephropathy via EGFR/AKT/GSK3β Signaling Pathway Based on Network Pharmacology and Experimental Validation
  Pengyu Wang, Qing Lan, Qi Huang, Ruyi Zhang, Shuo Zhang, Leiming Yang, Yan Song, Tong Wang, Guandi Ma, Xiufen Liu, Xiying Guo, Youzhi Zhang, Chao Liu
  Biology.2024; 13(8): 597.     CrossRef
• Network Pharmacology and Experimental Analysis to Explore the Effect and Mechanism of Modified Buyang Huanwu Decoction in the Treatment of Diabetic Nephropathy
  Fan Yang, Limin Pan, Xiaoyun Zhang, Jiaan Huang, Yan Liu, Peixuan Li, Yuehua Wang
  Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3249.     CrossRef
• Gestione perioperatoria del paziente diabetico adulto
  M. Raucoules-Aimé, T. Thierry Nessan Ouattara
  EMC - Anestesia-Rianimazione.2023; 28(1): 1.     CrossRef
• Pyruvate Kinase M2: A New Biomarker for the Early Detection of Diabetes-Induced Nephropathy
  Yeon Su Park, Joo Hee Han, Jae Hyeon Park, Ji Soo Choi, Seung Hyeon Kim, Hyung Sik Kim
  International Journal of Molecular Sciences.2023; 24(3): 2683.     CrossRef
• Tratamiento perioperatorio del paciente diabético adulto
  M. Raucoules-Aimé, T. Thierry Nessan Ouattara
  EMC - Anestesia-Reanimación.2023; 49(1): 1.     CrossRef
• Renal Protection of Mineralocorticoid Receptor Antagonist, Finerenone, in Diabetic Kidney Disease
  Dong-Lim Kim, Seung-Eun Lee, Nan Hee Kim
  Endocrinology and Metabolism.2023; 38(1): 43.     CrossRef
• The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease
  Xijian Wang, Liang Ren, Ying Huang, Zhengang Feng, Guangdi Zhang, Houyong Dai
  Clinica Chimica Acta.2023; 547: 117448.     CrossRef
• Network pharmacology and molecular docking technology-based predictive study of the active ingredients and potential targets of rhubarb for the treatment of diabetic nephropathy
  Shaojie Fu, Yena Zhou, Cong Hu, Zhonggao Xu, Jie Hou
  BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
• Acrolein plays a culprit role in the pathogenesis of diabetic nephropathy in vitro and in vivo
  Zhen-Jie Tong, Chin-Wei Kuo, Po-Cheng Yen, Chih-Ching Lin, Ming-Tsun Tsai, Shing-Hwa Lu, Yi-Ping Chang, Wen-Sheng Liu, Han-Hsing Tsou, Hsiao-Wei Cheng, Hsiang-Tsui Wang
  European Journal of Endocrinology.2022; 187(4): 579.     CrossRef
• Probiotics ameliorates glycemic control of patients with diabetic nephropathy: A randomized clinical study
  Hongyang Jiang, Yan Zhang, Dongyan Xu, Qing Wang
  Journal of Clinical Laboratory Analysis.2021;[Epub]     CrossRef
• Blood Oxygen Level-Dependent (BOLD) MRI in Glomerular Disease
  Daniel R. Nemirovsky, Puneet Gupta, Sophia Hu, Raymond Wong, Avnesh S. Thakor
  Transplantology.2021; 2(2): 109.     CrossRef
• Amelioration of STZ-induced nephropathy in diabetic rats by saffron hydro alcoholic extract
  Jamal Amri, Mona Alaee, Seyed Amirhossein Latifi, Abbas Alimoradian, Mehdi Salehi
  Hormone Molecular Biology and Clinical Investigation.2021; 42(4): 411.     CrossRef
• Exosomes: Biomarkers and Therapeutic Targets of Diabetic Vascular Complications
  Anqi Chen, Hailing Wang, Ying Su, Chunlin Zhang, Yanmei Qiu, Yifan Zhou, Yan Wan, Bo Hu, Yanan Li
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Sodium-glucose cotransporter 2 inhibitors benefit to kidney and cardiovascular outcomes for patients with type 2 diabetes mellitus and chronic kidney disease 3b-4: A systematic review and meta-analysis of randomized clinical trials
  Haiyan Cao, Youxia Liu, Zhixia Tian, Yuhang Lian, Junya Jia, Ming Liu, Dong Li
  Diabetes Research and Clinical Practice.2021; 180: 109033.     CrossRef
• Proteinuria as a significant predictive factor for the progression of carotid artery atherosclerosis in non-albuminuric type 2 diabetes
  Young-eun Kim, Minyoung Lee, Yong-ho Lee, Eun Seok Kang, Bong-soo Cha, Byung-Wan Lee
  Diabetes Research and Clinical Practice.2021; 181: 109082.     CrossRef
• The Role of Mesenchymal Stromal Cells-Derived Small Extracellular Vesicles in Diabetes and Its Chronic Complications
  Fu-Xing-Zi Li, Xiao Lin, Feng Xu, Su-Kang Shan, Bei Guo, Li-Min Lei, Ming-Hui Zheng, Yi Wang, Qiu-Shuang Xu, Ling-Qing Yuan
  Frontiers in Endocrinology.2021;[Epub]     CrossRef
• Preparation of Ergosterol-Loaded Nanostructured Lipid Carriers for Enhancing Oral Bioavailability and Antidiabetic Nephropathy Effects
  Zhonghua Dong, Sajid Iqbal, Zhongxi Zhao
  AAPS PharmSciTech.2020;[Epub]     CrossRef
• Carbon dots as fluorescent nanoprobe for the determination of N-acetyl-β-d-glucosaminidase activity
  Jimei Ma, Heng Zhang, Fangfang Peng, Xiaoqing Yang, Zi-Long Li, Linhao Sun, Hong Jiang
  Analytica Chimica Acta.2020; 1101: 129.     CrossRef
• Coffee Consumption is Associated with a Decreased Risk of Incident Chronic Kidney Disease: A Systematic Review and Meta-analysis of Cohort Studies
  Thatsaphan Srithongkul, Patompong Ungprasert
  European Journal of Internal Medicine.2020; 77: 111.     CrossRef
• Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
  Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, Kiran Kalia, Rakesh K. Tekade
  Drug Discovery Today.2020; 25(5): 862.     CrossRef
• A meta-analysis of serum Hcy in diagnosis of diabetic nephropathy
  Xiaoling Zhou, Aijie Shi, Xiao Zhou
  Pteridines.2020; 31(1): 1.     CrossRef
• Link between ACE I/D gene polymorphism and dyslipidemia in diabetic nephropathy: A case-control study from Hyderabad, India
  UmmeNajiya Mahwish, KamakshiChaithri Ponnaluri, Babi Heera, SatishReddy Alavala, KRudrama Devi, SreeBhushan Raju, GSuman Latha, Parveen Jahan
  Indian Journal of Nephrology.2020; 30(2): 77.     CrossRef
• Assessment of urinary NGAL for differential diagnosis and progression of diabetic kidney disease
  Suyan Duan, Jiajia Chen, Lin Wu, Guangyan Nie, Lianqin Sun, Chengning Zhang, Zhimin Huang, Changying Xing, Bo Zhang, Yanggang Yuan
  Journal of Diabetes and its Complications.2020; 34(10): 107665.     CrossRef
• Urinary Proteins Detected Using Modern Proteomics Intervene in Early Type 2 Diabetic Kidney Disease – A Pilot Study
  Alina Golea-Secara, Cristian Munteanu, Mirela Sarbu, Octavian M Cretu, Silvia Velciov, Adrian Vlad, Flaviu Bob, Florica Gadalean, Cristina Gluhovschi, Oana Milas, Anca Simulescu, Maria Mogos-Stefan, Mihaela Patruica, Ligia Petrica, Alina D Zamfir
  Biomarkers in Medicine.2020; 14(16): 1521.     CrossRef
• Efficacy and safety of Shenkang injection as adjuvant therapy in patients with diabetic nephropathy
  Yanping Wang, Mingzhu Li, Chenyun Li, Sheng Xu, Jiangfeng Wu, Gaochuan Zhang, Yuanyuan Cai
  Medicine.2020; 99(52): e23821.     CrossRef
• A Nucleoside/Nucleobase-Rich Extract from Cordyceps Sinensis Inhibits the Epithelial–Mesenchymal Transition and Protects against Renal Fibrosis in Diabetic Nephropathy
  Zhonghua Dong, Yueyue Sun, Guangwei Wei, Siying Li, Zhongxi Zhao
  Molecules.2019; 24(22): 4119.     CrossRef
• Lack of Association between Past Helicobacter pylori Infection and Diabetes: A Two-Cohort Study
  Jeung Hui Pyo, Hyuk Lee, Sung Chul Choi, Soo Jin Cho, Yoon-Ho Choi, Yang Won Min, Byung-Hoon Min, Jun Haeng Lee, Heejin Yoo, Kyunga Kim, Jae J. Kim
  Nutrients.2019; 11(8): 1874.     CrossRef
• Serum Homocysteine, cystatin C as Biomarkers for Progression of Diabetic Nephropathy
  Weihai Xu, Suhua Tang, Meijuan Xiang, Jianyun Peng
  Pteridines.2019; 30(1): 183.     CrossRef
• Serum leptin in diabetic nephropathy male patients from Gaza Strip
  Maged M. Yassin, Ayman M. AbuMustafa, Mohamed M. Yassin
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(2): 1245.     CrossRef
• Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Jae Hyun Bae, Eun-Gee Park, Sunhee Kim, Sin Gon Kim, Seokyung Hahn, Nam Hoon Kim
  Scientific Reports.2019;[Epub]     CrossRef
• Association between nonalbumin proteinuria and renal tubular damage of N-acetyl-β-d-glucosaminidase and its clinical relevance in patients with type 2 diabetes without albuminuria
  Eugene Han, Mi-Kyung Kim, Yong-ho Lee, Hye Soon Kim, Byung-Wan Lee
  Journal of Diabetes and its Complications.2019; 33(3): 255.     CrossRef
• Supplementation of Abelmoschus manihot Ameliorates Diabetic Nephropathy and Hepatic Steatosis by Activating Autophagy in Mice
  Hwajin Kim, Theodomir Dusabimana, So Ra Kim, Jihyun Je, Kyuho Jeong, Min Cheol Kang, Kye Man Cho, Hye Jung Kim, Sang Won Park
  Nutrients.2018; 10(11): 1703.     CrossRef
• Perioperative management of adult diabetic patients. Preoperative period
  Gaëlle Cheisson, Sophie Jacqueminet, Emmanuel Cosson, Carole Ichai, Anne-Marie Leguerrier, Bogdan Nicolescu-Catargi, Alexandre Ouattara, Igor Tauveron, Paul Valensi, Dan Benhamou
  Anaesthesia Critical Care & Pain Medicine.2018; 37: S9.     CrossRef
• Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement
  E. Cosson, B. Catargi, G. Cheisson, S. Jacqueminet, C. Ichai, A.-M. Leguerrier, A. Ouattara, I. Tauveron, E. Bismuth, D. Benhamou, P. Valensi
  Diabetes & Metabolism.2018; 44(3): 200.     CrossRef
• MicroRNA‐326‐3p ameliorates high glucose and ox‐LDL‐IC‐ induced fibrotic injury in renal mesangial cells by targeting FcγRIII
  Yiting Wang, Rui Zhang, Junlin Zhang, Fang Liu
  Nephrology.2018; 23(11): 1031.     CrossRef
• Urinary Extracellular Vesicle
  Wei-Cheng Xu, Ge Qian, Ai-Qun Liu, Yong-Qiang Li, He-Qun Zou
  Chinese Medical Journal.2018; 131(11): 1357.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with Diabetes
  Eugene Han, Gyuri Kim, Ji-Yeon Lee, Yong-ho Lee, Beom Seok Kim, Byung-Wan Lee, Bong-Soo Cha, Eun Seok Kang
  Endocrinology and Metabolism.2017; 32(2): 274.     CrossRef
• WITHDRAWN: Salvianolate attenuates renal fibrosis in rat models of diabetic nephropathy by inhibiting inflammation and oxidative stress mechanisms
  Chongxiang Xiong, Jianrao Lu, Xinhua Wang, Monica V. Masucci
  Biochemical and Biophysical Research Communications.2017;[Epub]     CrossRef
• Diffusion tensor imaging of the renal cortex in diabetic patients: correlation with urinary and serum biomarkers
  Ahmed Abdel Khalek Abdel Razek, Mohammad Alsayed Abd Alhamid Al-Adlany, Alhadidy Mohammed Alhadidy, Mohammed Ali Atwa, Naglaa Elsayed Abass Abdou
  Abdominal Radiology.2017; 42(5): 1493.     CrossRef
• Texte 2 : période préopératoire
  Gaëlle Cheisson, Sophie Jacqueminet, Emmanuel Cosson, Carole Ichai, Anne-Marie Leguerrier, Bogdan Nicolescu-Catargi, Alexandre Ouattara, Igor Tauveron, Paul Valensi, Dan Benhamou
  Anesthésie & Réanimation.2017; 3(3): 218.     CrossRef
• Global Cardiovascular and Renal Outcomes of Reduced GFR
  Bernadette Thomas, Kunihiro Matsushita, Kalkidan Hassen Abate, Ziyad Al-Aly, Johan Ärnlöv, Kei Asayama, Robert Atkins, Alaa Badawi, Shoshana H. Ballew, Amitava Banerjee, Lars Barregård, Elizabeth Barrett-Connor, Sanjay Basu, Aminu K. Bello, Isabela Bensen
  Journal of the American Society of Nephrology.2017; 28(7): 2167.     CrossRef
• Salvia miltiorrhizaLipophilic Fraction Attenuates Oxidative Stress in Diabetic Nephropathy through Activation of Nuclear Factor Erythroid 2-Related Factor 2
  Lin An, Mei Zhou, Faiz M. M. T. Marikar, Xue-Wen Hu, Qiu-Yun Miao, Ping Li, Jun Chen
  The American Journal of Chinese Medicine.2017; 45(07): 1441.     CrossRef
• Addition of nonalbumin proteinuria to albuminuria improves prediction of type 2 diabetic nephropathy progression
  Jong Ho Kim, Seo Young Oh, Eun Heui Kim, Min Jin Lee, Yun Kyung Jeon, Bo Hyun Kim, Jin Mi Kim, Yong Ki Kim, Sang Soo Kim, In Joo Kim
  Diabetology & Metabolic Syndrome.2017;[Epub]     CrossRef
• Reversal of Early Diabetic Nephropathy by Islet Transplantation under the Kidney Capsule in a Rat Model
  Yunqiang He, Ziqiang Xu, Mingshi Zhou, Minmin Wu, Xuehai Chen, Silu Wang, Kaiyan Qiu, Yong Cai, Hongxing Fu, Bicheng Chen, Mengtao Zhou
  Journal of Diabetes Research.2016; 2016: 1.     CrossRef

Management of diabetic complications has been a worldwide major global health issue for decades. Recent studies from many parts of the world indicate improvement in this area. However, it is unknown if such an improvement is being realized in Koreans. Although there is limited information regarding diabetic retinopathy management among Koreans, recent epidemiologic studies have indicated improved screening rates and less frequent visual impairment among type 2 diabetics. Moreover, results achieved with new diagnostic and treatment modalities aimed to improve diabetic retinopathy management are encouraging for both physicians and patients.

Citations

Citations to this article as recorded by  

• Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema
  Sang Youl Rhee, Eun Sung Jung, Dong Ho Suh, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
  Scientific Reports.2021;[Epub]     CrossRef
• Urine protein: Urine creatinine ratio correlation with diabetic retinopathy
  Samya Mujeeb, Gladys R Rodrigues, Rajesh R Nayak, Ajay R Kamath, Sumana J Kamath, Gurudutt Kamath
  Indian Journal of Ophthalmology.2021; 69(11): 3359.     CrossRef
• Diabetic Retinopathy in the Asia-Pacific
  
  Asia-Pacific Journal of Ophthalmology.2019;[Epub]     CrossRef
• Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy
  Sang Youl Rhee, Eun Sung Jung, Hye Min Park, Su Jin Jeong, Kiyoung Kim, Suk Chon, Seung-Young Yu, Jeong-Taek Woo, Choong Hwan Lee
  Metabolomics.2018;[Epub]     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Normal-to-mildly increased albuminuria predicts the risk for diabetic retinopathy in patients with type 2 diabetes
  Min-Kyung Lee, Kyung-Do Han, Jae-Hyuk Lee, Seo-Young Sohn, Oak-Kee Hong, Jee-Sun Jeong, Mee-Kyoung Kim, Ki-Hyun Baek, Ki-Ho Song, Hyuk-Sang Kwon
  Scientific Reports.2017;[Epub]     CrossRef

Glucagon-like peptide-1 (GLP-1) is a member of the proglucagon incretin family, and GLP-1 receptor agonists (RAs) have been introduced as a new class of antidiabetic medications in the past decade. The benefits of GLP-1 RAs are derived from their pleiotropic effects, which include glucose-dependent insulin secretion, suppressed glucagon secretion, and reduced appetite. Moreover, GLP-1 RAs also exert beneficial roles on multiple organ systems in which the GLP-1 receptors exist, including the cardiovascular system. Cardiovascular effects of GLP-1 RAs have been of great interest since the burden from cardiovascular diseases (CVD) has been unbearably increasing in a diabetic population worldwide, despite strict glycemic control and advanced therapeutic techniques to treat CVD. Preclinical studies have already demonstrated the beneficial effects of GLP-1 on myocardium and vascular endothelium, and many clinical studies evaluating changes in surrogate markers of CVD have suggested potential benefits from the use of GLP-1 RAs. Data from numerous clinical trials primarily evaluating the antihyperglycemic effects of multiple GLP-1 RAs have also revealed that changes in most CVD risk markers reported as secondary outcomes have been in favor of GLP-1 RAs treatment. However, to date, there is only one randomized clinical trial of GLP-1 RAs (the ELIXA study) evaluating major cardiovascular events as their primary outcomes, and in this study, a neutral cardiovascular effect of lixisenatide was observed in high-risk diabetic subjects. Therefore, the results of ongoing CVD outcome trials with the use of GLP-1 RAs should be awaited to elucidate the translation of benefits previously seen in CVD risk marker studies into large clinical trials with primary cardiovascular outcomes.

Citations

Citations to this article as recorded by  

• Can glucagon-like peptide-1 receptor agonists induce asthma? An analysis of the FAERS database
  Mario Cazzola, Maria Gabriella Matera, Luigino Calzetta, Davide Lauro, Paola Rogliani
  Journal of Asthma.2024; 61(12): 1638.     CrossRef
• Unveiling the Potential Role of Glucagon-Like Peptide-1 (Glp-1) Receptor Agonists in Offering Protection of the Cardiovascular, Renal, and Neural Systems: An Updated Narrative Review
  Divya Rajagopal, Sulthan Al Rashid, Monisha Prasad, Mohammad Fareed
  Cureus.2024;[Epub]     CrossRef
• Cardioprotective Actions of a Glucagon‐like Peptide‐1 Receptor Agonist on Hearts Donated After Circulatory Death
  Sachiko Kadowaki, M. Ahsan Siraj, Weiden Chen, Jian Wang, Marlee Parker, Anita Nagy, Chun‐Po Steve Fan, Kyle Runeckles, Jing Li, Junko Kobayashi, Christoph Haller, Mansoor Husain, Osami Honjo
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• The role of dipeptidyl peptidase-IV in abdominal aortic aneurysm pathogenesis: A systematic review
  Elisha Ngetich, Pierfrancesco Lapolla, Anirudh Chandrashekar, Ashok Handa, Regent Lee
  Vascular Medicine.2022; 27(1): 77.     CrossRef
• Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors
  Jasna Klen, Vita Dolžan
  International Journal of Molecular Sciences.2022; 23(7): 3451.     CrossRef
• Glucagon-like peptide-1 (GLP-1) receptor agonists and cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of double-blind, randomized, placebo-controlled clinical trials
  Jing Qin, Li Song
  BMC Endocrine Disorders.2022;[Epub]     CrossRef
• Role of G-protein coupled receptor (GPCRs)/(GPR-120) as an agonists in diabetic wound healing
  Jagat Pal Yadav, Dinesh Kumar Patel, Prateek Pathak, Maria Grishina
  Obesity Medicine.2022; 36: 100466.     CrossRef
• Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms
  Bruno Vergès, Victor Aboyans, Denis Angoulvant, Pierre Boutouyrie, Bertrand Cariou, Fabien Hyafil, Kamel Mohammedi, Pierre Amarenco
  Cardiovascular Diabetology.2022;[Epub]     CrossRef
• Changing Fields-Diabetes Medications Invading the Cardiovascular Space
  Lauren D. Breite, Mackenzie Steck, Brandon Tate Cutshall, Samarth P. Shah, Brandon E. Cave
  Current Problems in Cardiology.2021; 46(3): 100736.     CrossRef
• PEGDA/HA mineralized hydrogel loaded with Exendin4 promotes bone regeneration in rat models with bone defects by inducing osteogenesis
  Wei Liu, Xiaowei Jing, Zhiwen Xu, Chong Teng
  Journal of Biomaterials Applications.2021; 35(10): 1337.     CrossRef
• Metabolite G-Protein Coupled Receptors in Cardio-Metabolic Diseases
  Derek Strassheim, Timothy Sullivan, David C. Irwin, Evgenia Gerasimovskaya, Tim Lahm, Dwight J. Klemm, Edward C. Dempsey, Kurt R. Stenmark, Vijaya Karoor
  Cells.2021; 10(12): 3347.     CrossRef
• PPG neurons in the nucleus of the solitary tract modulate heart rate but do not mediate GLP-1 receptor agonist-induced tachycardia in mice
  Marie K. Holt, Daniel R. Cook, Daniel I. Brierley, James E. Richards, Frank Reimann, Alexander V. Gourine, Nephtali Marina, Stefan Trapp
  Molecular Metabolism.2020; 39: 101024.     CrossRef
• A glycosylated Fc‐fused glucagon‐like peptide‐1 receptor agonist exhibits equivalent glucose lowering to but fewer gastrointestinal side effects than dulaglutide
  In Bok An, Mi Sun Byun, Sang In Yang, Yuri Choi, Jung Won Woo, Hak Chul Jang, Young Chul Sung
  Diabetes, Obesity and Metabolism.2020; 22(8): 1455.     CrossRef
• Glucagon-Like Peptide-1 Receptor Agonists in Adult Patients With Type 2 Diabetes: Review of Cardiovascular Outcome Trials
  Elodie M. Varin, Brent A. McLean, Julie A. Lovshin
  Canadian Journal of Diabetes.2020; 44(1): 68.     CrossRef
• Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
  Alexandros Sachinidis, Dragana Nikolic, Anca Pantea Stoian, Nikolaos Papanas, Omer Tarar, Ali A. Rizvi, Manfredi Rizzo
  Metabolism.2020; 111: 154343.     CrossRef
• GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction
  Lili Zhang, Jiali Tian, Sujuan Diao, Guowei Zhang, Mochao Xiao, Dong Chang
  Chemico-Biological Interactions.2020; 332: 109252.     CrossRef
• Predictors of Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist Therapy in Patients with Type 2 Diabetes and Obesity
  Alina Yu. Babenko, Daria A. Savitskaya, Yulia A. Kononova, Aleksandra Yu. Trofimova, Anna V. Simanenkova, Elena Yu. Vasilyeva, Evgeny V. Shlyakhto
  Journal of Diabetes Research.2019; 2019: 1.     CrossRef
• Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
  Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
  Obesity and metabolism.2019; 15(4): 22.     CrossRef
• Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials
  Yu Mi Kang, Yun Kyung Cho, Jiwoo Lee, Seung Eun Lee, Woo Je Lee, Joong-Yeol Park, Ye-Jee Kim, Chang Hee Jung, Michael A. Nauck
  Diabetes & Metabolism Journal.2019; 43(4): 410.     CrossRef
• Diabetes, Incretin Therapy and Thoracic Aortic Aneurysm – What Does the Evidence Show?
  Camilla Krizhanovskii , Anders Franco-Cereceda
  Current Vascular Pharmacology.2019; 17(5): 432.     CrossRef
• Cardiovascular Effects of Different GLP-1 Receptor Agonists in Patients with Type 2 Diabetes
  Gül Bahtiyar, Jean Pujals-Kury, Alan Sacerdote
  Current Diabetes Reports.2018;[Epub]     CrossRef
• Efficacy From Strange Sources
  Lawrence J. Lesko
  Clinical Pharmacology & Therapeutics.2018; 103(2): 253.     CrossRef
• Exogenous SERP1 attenuates restenosis by restoring GLP-1 receptor activity in diabetic rats following vascular injury
  Lishuai Feng, Jianbo Wang, Xu Ma
  Biomedicine & Pharmacotherapy.2018; 103: 290.     CrossRef
• Exenatide exhibits anti‐inflammatory properties and modulates endothelial response to tumor necrosis factor α‐mediated activation
  Wojciech Garczorz, Enrique Gallego‐Colon, Agnieszka Kosowska, Agnieszka Kłych‐Ratuszny, Michał Woźniak, Wiesław Marcol, K.J. Niesner, Tomasz Francuz
  Cardiovascular Therapeutics.2018;[Epub]     CrossRef
• Molecular and clinical roles of incretin-based drugs in patients with heart failure
  Bassant Orabi, Rasha Kaddoura, Amr S. Omar, Cornelia Carr, Abdulaziz Alkhulaifi
  Heart Failure Reviews.2018; 23(3): 363.     CrossRef
• The effects of Exendin-4 on bone marrow-derived mesenchymal cells
  Paola Luciani, Benedetta Fibbi, Benedetta Mazzanti, Cristiana Deledda, Lara Ballerini, Alessandra Aldinucci, Susanna Benvenuti, Riccardo Saccardi, Alessandro Peri
  Endocrine.2018; 60(3): 423.     CrossRef
• Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic
  David M. Williams, Natasha Shrikrishnapalasuriyar, Waheeba Syed, Win L. Yin, Richard Chudleigh, Stephen C. Bain, David E. Price, Jeffrey W. Stephens
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2018; 12(6): 1079.     CrossRef
• Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
  Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al-Salami, Karmen Stankov, Momir Mikov
  Frontiers in Pharmacology.2018;[Epub]     CrossRef
• Cardiovascular Outcome Trials of Diabetes and Obesity Drugs: Implications for Conditional Approval and Early Phase Clinical Development
  Andrew J. Krentz, Gerardo Rodriguez-Araujo
  Pharmaceutical Medicine.2017; 31(6): 399.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• GLP-1R as a Target for the Treatment of Diabetic Retinopathy: Friend or Foe?
  Rafael Simó, Cristina Hernández
  Diabetes.2017; 66(6): 1453.     CrossRef
• GLP-1 receptor agonists and heart failure in diabetes
  André J. Scheen
  Diabetes & Metabolism.2017; 43: 2S13.     CrossRef
• Effects of Incretin-Based Therapies on Diabetic Microvascular Complications
  Yu Mi Kang, Chang Hee Jung
  Endocrinology and Metabolism.2017; 32(3): 316.     CrossRef
• Historique des études cardiovasculaires : de l’UGDP… aux dernières études
  A.-J. Scheen
  Médecine des Maladies Métaboliques.2017; 11: 2S15.     CrossRef
• Cardiovascular safety and benefits of GLP-1 receptor agonists
  Niels B. Dalsgaard, Andreas Brønden, Tina Vilsbøll, Filip K. Knop
  Expert Opinion on Drug Safety.2017; 16(3): 351.     CrossRef

Citations

Citations to this article as recorded by  

• Captopril's influence on Danio rerio embryonic development: Unveiling significant toxic outcomes at environmentally relevant concentrations
  Fernando García-Valdespino, Gustavo Axel Elizalde-Velázquez, Selene Elizabeth Herrera-Vázquez, Leobardo Manuel Gómez-Oliván
  Science of The Total Environment.2024; 933: 173179.     CrossRef
• Comparison of four confirmatory tests for the diagnosis of primary aldosteronism: Bayesian analysis in the absence of a gold standard
  Hang Shen, Wenjin Luo, Jinbo Hu, Jun Yang, Ying Song, Xiangjun Chen, Yi Yang, Linqiang Ma, Qingfeng Cheng, Zhihong Wang, Qifu Li, Shumin Yang, Qifu Li, Ying Song, Shumin Yang, Wenwen He, Mei Mei, Jinbo Hu, Suxin Luo, Kangla Liao, Yao Zhang, Yunfeng He, Yi
  Endocrine.2024; 85(3): 1417.     CrossRef
• Exclusion Tests in Unilateral Primary Aldosteronism (ExcluPA) Study
  Rui Zhu, Tungalagtamir Shagjaa, Giacomo Rossitto, Brasilina Caroccia, Teresa Maria Seccia, Dario Gregori, Gian Paolo Rossi
  The Journal of Clinical Endocrinology & Metabolism.2023; 108(2): 496.     CrossRef
• Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling
  Xinyu Liu, Chao Guo, Jin Bian, Sufang Hao, Ying Lou, Huimin Zhang, Xianliang Zhou, Jun Cai, Wenjun Ma
  Frontiers in Endocrinology.2023;[Epub]     CrossRef
• Performance of Confirmatory Tests for Diagnosing Primary Aldosteronism: a Systematic Review and Meta-Analysis
  Alexander A. Leung, Christopher J. Symonds, Gregory L. Hundemer, Paul E. Ronksley, Diane L. Lorenzetti, Janice L. Pasieka, Adrian Harvey, Gregory A. Kline
  Hypertension.2022; 79(8): 1835.     CrossRef
• Baseline Plasma Aldosterone Level and Renin Activity Allowing Omission of Confirmatory Testing in Primary Aldosteronism
  Junji Kawashima, Eiichi Araki, Mitsuhide Naruse, Isao Kurihara, Katsutoshi Takahashi, Kouichi Tamura, Hiroki Kobayashi, Shintaro Okamura, Shozo Miyauchi, Koichi Yamamoto, Shoichiro Izawa, Tomoko Suzuki, Akiyo Tanabe
  The Journal of Clinical Endocrinology & Metabolism.2020; 105(5): e1990.     CrossRef
• The number of positive confirmatory tests is associated with the clinical presentation and incidence of cardiovascular and cerebrovascular events in primary aldosteronism
  Aya Saiki, Daisuke Tamada, Reiko Hayashi, Kosuke Mukai, Tetsuhiro Kitamura, Mitsuyoshi Takahara, Michio Otsuki, Iichiro Shimomura
  Hypertension Research.2019; 42(8): 1186.     CrossRef
• The characteristics of captopril challenge test–positive patients using various criteria
  Satoshi Kidoguchi, Naoki Sugano, Naomi Hayashi-Ishikawa, Norihiko Morisawa, Goro Tokudome, Takashi Yokoo
  Journal of the Renin-Angiotensin-Aldosterone System.2019;[Epub]     CrossRef
• Confirmatory tests for the diagnosis of primary aldosteronism: A systematic review and meta‐analysis
  Sicen Wu, Jun Yang, Jinbo Hu, Ying Song, Wenwen He, Shumin Yang, Rong Luo, Qifu Li
  Clinical Endocrinology.2019; 90(5): 641.     CrossRef
• The captopril challenge test for diagnosing primary Aldosteronism in a Chinese population
  Ke-ying Zhu, Yan Zhang, Wen-jing Zhang, Hong-yun Li, Wen-huan Feng, Da-long Zhu, Ping Li
  BMC Endocrine Disorders.2019;[Epub]     CrossRef
• Confirmatory Tests for the Diagnosis of Primary Aldosteronism
  Ying Song, Shumin Yang, Wenwen He, Jinbo Hu, Qingfeng Cheng, Yue Wang, Ting Luo, Linqiang Ma, Qianna Zhen, Suhua Zhang, Mei Mei, Zhihong Wang, Hua Qing, Dennis Bruemmer, Bin Peng, Qifu Li
  Hypertension.2018; 71(1): 118.     CrossRef
• Evaluation of the Saline Infusion Test and the Captopril Challenge Test in Chinese Patients With Primary Aldosteronism
  Xiao Meng, Yanyan Li, Xiaohao Wang, Jianwei Li, Yuping Liu, Yerong Yu
  The Journal of Clinical Endocrinology & Metabolism.2018; 103(3): 853.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice
  A Ram Hong, Jung Hee Kim, Kyeong Seon Park, Kyong Young Kim, Ji Hyun Lee, Sung Hye Kong, Seo Young Lee, Chan Soo Shin, Sang Wan Kim, Seong Yeon Kim
  European Journal of Endocrinology.2017; 177(6): 475.     CrossRef
• Agkihpin, a novel SVTLE from Gloydius halys Pallas, promotes platelet aggregation in vitro and inhibits thrombus formation in vivo in murine models of thrombosis
  Huiqiong Xie, Miao Huang, Qiping Hu, Kejian Sun, Huayu Wu, Wei Shu, Xiaolong Li, Ling Fang
  Toxicon.2016; 122: 78.     CrossRef

Citations

Citations to this article as recorded by  

• Neurological dysfunction screening in a cohort of adolescents with type 1 diabetes: a six-year follow-up
  Davide Tinti, Carlotta Canavese, Cecilia Nobili, Daniele Marcotulli, Erika Daniele, Ivana Rabbone, Luisa de Sanctis
  Frontiers in Medicine.2024;[Epub]     CrossRef
• The progress of clinical research on the detection of 1,5-anhydroglucitol in diabetes and its complications
  Huijuan Xu, Junhua Pan, Qiu Chen
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Mobile Healthcare System Provided by Primary Care Physicians Improves Quality of Diabetes Care
  Tae Jung Oh, Jie-Eun Lee, Seok Kim, Sooyoung Yoo, Hak Chul Jang
  CardioMetabolic Syndrome Journal.2021; 1(1): 88.     CrossRef
• Effects of mobile phone application combined with or without self‐monitoring of blood glucose on glycemic control in patients with diabetes: A randomized controlled trial
  Yuan Yu, Qun Yan, Huizhi Li, Hongmei Li, Lin Wang, Hua Wang, Yiyun Zhang, Lei Xu, Zhaosheng Tang, Xinfeng Yan, Yinghua Chen, Huili He, Jie Chen, Bo Feng
  Journal of Diabetes Investigation.2019; 10(5): 1365.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• A Diet Diverse in Bamboo Parts is Important for Giant Panda (Ailuropoda melanoleuca) Metabolism and Health
  Hairui Wang, Heju Zhong, Rong Hou, James Ayala, Guangmang Liu, Shibin Yuan, Zheng Yan, Wenping Zhang, Yuliang Liu, Kailai Cai, Zhigang Cai, He Huang, Zhihe Zhang, De Wu
  Scientific Reports.2017;[Epub]     CrossRef
• Low and exacerbated levels of 1,5-anhydroglucitol are associated with cardiovascular events in patients after first-time elective percutaneous coronary intervention
  Shuhei Takahashi, Kazunori Shimada, Katsumi Miyauchi, Tetsuro Miyazaki, Eiryu Sai, Manabu Ogita, Shuta Tsuboi, Hiroshi Tamura, Shinya Okazaki, Tomoyuki Shiozawa, Shohei Ouchi, Tatsuro Aikawa, Tomoyasu Kadoguchi, Hamad Al Shahi, Takuma Yoshihara, Makoto Hi
  Cardiovascular Diabetology.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Changing landscape of diabetes in Asia – What are the unmet needs?
  Andrea OY Luk
  Journal of Diabetes Investigation.2024; 15(4): 402.     CrossRef
• High level of gamma-glutamyltransferase is a possible risk factor for psoriasis: A nationwide population-based cohort study
  Jongwook Oh, Kyungdo Han, Jee Yun Doh, Heon Yung Gee, Ji Hyun Lee
  Indian Journal of Dermatology, Venereology and Leprology.2024; 0: 1.     CrossRef
• Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
  Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
  Intestinal Research.2023; 21(2): 252.     CrossRef
• The role of nutritional status in the relationship between diabetes and health-related quality of life
  Sohyun Park, Sukyoung Jung, Hyunsook Yoon
  Nutrition Research and Practice.2022; 16(4): 505.     CrossRef
• Lifetime risk of developing diabetes in Chinese people with normoglycemia or prediabetes: A modeling study
  Xinge Zhang, Hongjiang Wu, Baoqi Fan, Mai Shi, Eric S. H. Lau, Aimin Yang, Elaine Chow, Alice P. S. Kong, Juliana C. N. Chan, Ronald C. W. Ma, Andrea O. Y. Luk, Claudia Langenberg
  PLOS Medicine.2022; 19(7): e1004045.     CrossRef
• Rising Incidence of Diabetes in Young Adults in South Korea: A National Cohort Study
  Hyun Ho Choi, Giwoong Choi, Hojun Yoon, Kyoung Hwa Ha, Dae Jung Kim
  Diabetes & Metabolism Journal.2022; 46(5): 803.     CrossRef
• Association between Age-Related Macular Degeneration and the Risk of Diabetes Mellitus: A Nationwide Cohort Study
  Wonyoung Jung, Je Moon Yoon, Kyungdo Han, Bongseong Kim, Sungsoon Hwang, Dong Hui Lim, Dong Wook Shin
  Biomedicines.2022; 10(10): 2435.     CrossRef
• Relationship between Dermatitis and Joint Replacement
  Joon Woo Jung, Minkook Son, Soo Hyun Jeong, Kwang Joong Kim, Kwang Ho Kim, Eun Joo Park
  Indian Journal of Dermatology.2022; 67(3): 312.     CrossRef
• Prediction of type 2 diabetes using genome-wide polygenic risk score and metabolic profiles: A machine learning analysis of population-based 10-year prospective cohort study
  Seok-Ju Hahn, Suhyeon Kim, Young Sik Choi, Junghye Lee, Jihun Kang
  eBioMedicine.2022; 86: 104383.     CrossRef
• A Novel User Utility Score for Diabetes Management Using Tailored Mobile Coaching: Secondary Analysis of a Randomized Controlled Trial
  Min-Kyung Lee, Da Young Lee, Hong-Yup Ahn, Cheol-Young Park
  JMIR mHealth and uHealth.2021; 9(2): e17573.     CrossRef
• Estimating the disease burden of Korean type 2 diabetes mellitus patients considering its complications
  Juyoung Kim, Seok-Jun Yoon, Min-Woo Jo, Brecht Devleesschauwer
  PLOS ONE.2021; 16(2): e0246635.     CrossRef
• Positive association between actinic keratosis and internal malignancies: a nationwide population-based cohort study
  Young Bok Lee, Ji Hyun Lee, Yeong Ho Kim, Ji Min Seo, Dong Soo Yu, Yong Gyu Park, Kyung Do Han
  Scientific Reports.2021;[Epub]     CrossRef
• Herpes Zoster and Subsequent Cancer Risk: A Nationwide Population-Based Cohort Study in Korea
  Miri Kim, Kyungdo Han, Seung Ah Yoo, Ji Hyun Lee
  Dermatology.2021; 237(1): 73.     CrossRef
• Identification of herpes zoster high‐risk group using Charlson comorbidity index: A nationwide retrospective cohort study
  Soo Ick Cho, Dong Hun Lee, Young Min Park
  The Journal of Dermatology.2020; 47(1): 47.     CrossRef
• Increased risk of Alzheimer’s disease in patients with psoriasis: a nationwide population-based cohort study
  Miri Kim, Hyo Eun Park, Si-Hyung Lee, Kyungdo Han, Ji Hyun Lee
  Scientific Reports.2020;[Epub]     CrossRef
• The incidence rates and risk factors of Parkinson disease in patients with psoriasis: A nationwide population-based cohort study
  Ji Hyun Lee, Kyungdo Han, Heon Yung Gee
  Journal of the American Academy of Dermatology.2020; 83(6): 1688.     CrossRef
• Site-specific cancer risk in patients with type 2 diabetes: a nationwide population-based cohort study in Korea
  Suk Kyeong Kim, Ju-Young Jang, Dong-Lim Kim, Young A Rhyu, Suh Eun Lee, Seung-Hyun Ko, Kyungdo Han, Kee-Ho Song
  The Korean Journal of Internal Medicine.2020; 35(3): 641.     CrossRef
• Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: A retrospective cohort study
  Andrea O. Y. Luk, Calvin Ke, Eric S. H. Lau, Hongjiang Wu, William Goggins, Ronald C. W. Ma, Elaine Chow, Alice P. S. Kong, Wing-Yee So, Juliana C. N. Chan, Sanjay Basu
  PLOS Medicine.2020; 17(2): e1003052.     CrossRef
• Long‐term risk of congestive heart failure in younger breast cancer survivors: A nationwide study by the SMARTSHIP group
  Jihyoun Lee, Ho Hur, Jong Won Lee, Hyun Jo Youn, Kyungdo Han, Nam Won Kim, So‐Youn Jung, Zisun Kim, Ku Sang Kim, Min Hyuk Lee, Se‐Hwan Han, Sung Hoo Jung, Il Yong Chung
  Cancer.2020; 126(1): 181.     CrossRef
• The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
  Juliana C N Chan, Lee-Ling Lim, Nicholas J Wareham, Jonathan E Shaw, Trevor J Orchard, Ping Zhang, Eric S H Lau, Björn Eliasson, Alice P S Kong, Majid Ezzati, Carlos A Aguilar-Salinas, Margaret McGill, Naomi S Levitt, Guang Ning, Wing-Yee So, Jean Adams,
  The Lancet.2020; 396(10267): 2019.     CrossRef
• Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
  Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
  Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
• Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data
  Ji Hong You, Sun Ok Song, Se Hee Park, Kyoung Hye Park, Joo Young Nam, Dong Wook Kim, Hyun Min Kim, Dong-Jun Kim, Yong-ho Lee, Byung-Wan Lee
  Endocrinology and Metabolism.2019; 34(3): 275.     CrossRef
• Response: Trends in Hyperglycemic Crisis Hospitalizations and in- and out-of-Hospital Mortality in the Last Decade Based on Korean National Health Insurance Claims Data (Endocrinol Metab 2019;34:275–81, Ji Hong You et al.)
  Ji Hong You, Sun Ok Song
  Endocrinology and Metabolism.2019; 34(4): 424.     CrossRef
• A simple screening score to predict diabetes in cancer patients
  Ji-Su Kim, Sun-Hye Ko, Myong Ki Baeg, Kyung-Do Han
  Medicine.2019; 98(51): e18354.     CrossRef
• Cancer risk in 892 089 patients with psoriasis in Korea: A nationwide population‐based cohort study
  Ji Hyun Lee, Hyo Jung Kim, Kyung Do Han, Ha‐Na Kim, Young Min Park, Jun Young Lee, Yong‐Gyu Park, Young Bok Lee
  The Journal of Dermatology.2019; 46(2): 95.     CrossRef
• Effects of sarpogrelate on microvascular complications with type 2 diabetes
  Hyunju Yoo, Inwhee Park, Dae Jung Kim, Sukhyang Lee
  International Journal of Clinical Pharmacy.2019; 41(2): 563.     CrossRef
• Presence of Metabolic Syndrome Components Is Associated with Tooth Loss in Middle-Aged Adults
  Min-Jeong Cho, Youn-Hee Choi, Hyeon Chang Kim, Jee-Seon Shim, Atsuo Amano, Ji-Young Kim, Keun-Bae Song
  Yonsei Medical Journal.2019; 60(6): 554.     CrossRef
• Ten-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013
  Kyeong Jin Kim, Tae Yeon Kwon, Sungwook Yu, Ji A Seo, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Sin Gon Kim, Yousung Park, Nam Hoon Kim
  Diabetes & Metabolism Journal.2018; 42(5): 394.     CrossRef
• Cancer risk by the subtype of alopecia
  Ji Hyun Lee, Yumee Song, Kyung Do Han, Young Min Park, Jun Young Lee, Yong-Gyu Park, Young Bok Lee
  Scientific Reports.2018;[Epub]     CrossRef
• Nationwide Analysis of Treatment Patterns for Korean Breast Cancer Survivors Using National Health Insurance Service Data
  Il Yong Chung, Jihyoun Lee, Suyeon Park, Jong Won Lee, Hyun Jo Youn, Jung Hwa Hong, Ho Hur
  Journal of Korean Medical Science.2018;[Epub]     CrossRef
• Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort: study protocol and results of the first 3 years of enrollment
  Jee-Seon Shim, Bo Mi Song, Jung Hyun Lee, Seung Won Lee, Ji Hye Park, Dong Phil Choi, Myung Ha Lee, Kyoung Hwa Ha, Dae Jung Kim, Sungha Park, Won-Woo Lee, Hyeon Chang Kim
  Epidemiology and Health.2017; 39: e2017016.     CrossRef
• Effectiveness of Vildagliptin in Clinical Practice: Pooled Analysis of Three Korean Observational Studies (the VICTORY Study)
  Sunghwan Suh, Sun Ok Song, Jae Hyeon Kim, Hyungjin Cho, Woo Je Lee, Byung-Wan Lee
  Journal of Diabetes Research.2017; 2017: 1.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef
• Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes Mellitus over 52 Weeks
  Soo Lim, Kyoung Min Kim, Sin Gon Kim, Doo Man Kim, Jeong-Taek Woo, Choon Hee Chung, Kyung Soo Ko, Jeong Hyun Park, Yongsoo Park, Sang Jin Kim, Hak Chul Jang, Dong Seop Choi
  Diabetes & Metabolism Journal.2017; 41(5): 377.     CrossRef
• Current status of managing diabetes mellitus in Korea
  Kyoung Hwa Ha, Dae Jung Kim
  The Korean Journal of Internal Medicine.2016; 31(5): 845.     CrossRef

Citations

Citations to this article as recorded by  

• Thyroid stimulating receptor autoantibodies
  Yumeng Gao, Ling Qiu, Songlin Yu, Xinqi Cheng
  Clinica Chimica Acta.2024; 559: 119700.     CrossRef
• US-based, Prospective, Blinded Study of Thyrotropin Receptor Antibody in Autoimmune Thyroid Disease
  Mark A Lupo, Paul D Olivo, Maximilian Luffy, Jan Wolf, George J Kahaly
  The Journal of Clinical Endocrinology & Metabolism.2024;[Epub]     CrossRef
• Dynamic Risk Model for the Medical Treatment of Graves’ Hyperthyroidism according to Treatment Duration
  Meihua Jin, Chae A Kim, Min Ji Jeon, Won Bae Kim, Tae Yong Kim, Won Gu Kim
  Endocrinology and Metabolism.2024; 39(4): 579.     CrossRef
• Analysis of Related Factors in Refractory Graves’ Disease
  鑫 王
  Advances in Clinical Medicine.2023; 13(08): 13439.     CrossRef
• Interpretation of Thyroid Autoantibodies in Hyperthyroidism
  Han-Sang Baek, Dong-Jun Lim
  The Korean Journal of Medicine.2023; 98(3): 132.     CrossRef
• The Early Changes in Thyroid-Stimulating Immunoglobulin Bioassay over Anti-Thyroid Drug Treatment Could Predict Prognosis of Graves’ Disease
  Jin Yu, Han-Sang Baek, Chaiho Jeong, Kwanhoon Jo, Jeongmin Lee, Jeonghoon Ha, Min Hee Kim, Jungmin Lee, Dong-Jun Lim
  Endocrinology and Metabolism.2023; 38(3): 338.     CrossRef
• Prediction of the recurrence risk of Graves' disease after antithyroid drug therapy
  Qiang Zhang, Ying Fu
  Environmental Disease.2023; 8(1): 7.     CrossRef
• Thyroid-Stimulatory Antibody as a Predictive Factor for Graves’ Disease Relapse
  Tiago Da Silva Santos, José Carlos Oliveira, Cláudia Freitas, André Couto de Carvalho
  Cureus.2022;[Epub]     CrossRef
• The Prediction Model Using Thyroid-stimulating Immunoglobulin Bioassay For Relapse of Graves’ Disease
  Han-Sang Baek, Jaejun Lee, Chai-Ho Jeong, Jeongmin Lee, Jeonghoon Ha, Kwanhoon Jo, Min-Hee Kim, Jae Hyoung Cho, Moo Il Kang, Dong-Jun Lim
  Journal of the Endocrine Society.2022;[Epub]     CrossRef
• Identification of patients with Graves’ disease who benefit from high-dose radioactive iodine therapy
  Shiro Watanabe, Shozo Okamoto, Kazumasa Akikawa, Noriyuki Miyamoto, Miyuki Okamura-Kawasaki, Yuko Uchiyama, Junki Takenaka, Takuya Toyonaga, Kenji Hirata, Kohsuke Kudo
  Annals of Nuclear Medicine.2022; 36(11): 923.     CrossRef
• The relationship between atherosclerotic disease and relapse during ATD treatment
  Xinxin Zhu, Yaguang Zhang, Xiaoyu Zhao, Xiaona Zhang, Zixuan Ru, Yanmeizhi Wu, Xu Yang, Boyu Hou, Hong Qiao
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• Antithyroid Drug Treatment in Graves’ Disease
  Jae Hoon Chung
  Endocrinology and Metabolism.2021; 36(3): 491.     CrossRef
• The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease
  Yulin Zhou, Mengxi Zhou, Yicheng Qi, Weiqing Wang, Xinxin Chen, Shu Wang
  Therapeutic Advances in Endocrinology and Metabolism.2021;[Epub]     CrossRef
• Changes in Thyroid Peroxidase and Thyroglobulin Antibodies Might Be Associated with Graves' Disease Relapse after Antithyroid Drug Therapy
  Yun Mi Choi, Mi Kyung Kwak, Sang Mo Hong, Eun-Gyoung Hong
  Endocrinology and Metabolism.2019; 34(3): 268.     CrossRef
• Graves' Disease: Can It Be Cured?
  Wilmar M. Wiersinga
  Endocrinology and Metabolism.2019; 34(1): 29.     CrossRef
• Medical Treatment of Graves' Disease
  Hyun-Kyung Chung
  International Journal of Thyroidology.2019; 12(2): 79.     CrossRef
• When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves’ disease be discontinued?
  Suyeon Park, Eyun Song, Hye-Seon Oh, Mijin Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Doo Man Kim, Won Bae Kim
  Endocrine.2019; 65(2): 348.     CrossRef
• Elevated Serum IL-17 Expression at Cessation Associated with Graves’ Disease Relapse
  Jianhui Li, Xiaohua Sun, Danzhen Yao, Jinying Xia
  International Journal of Endocrinology.2018; 2018: 1.     CrossRef
• Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center’s Experience in Korea
  Hyemi Kwon, Hye-Seon Oh, Mijin Kim, Suyeon Park, Min Ji Jeon, Won Gu Kim, Won Bae Kim, Young Kee Shong, Dong Eun Song, Jung Hwan Baek, Ki-Wook Chung, Tae Yong Kim
  The Journal of Clinical Endocrinology & Metabolism.2017; 102(6): 1917.     CrossRef
• Free Thyroxine, Anti-Thyroid Stimulating Hormone Receptor Antibody Titers, and Absence of Goiter Were Associated with Responsiveness to Methimazole in Patients with New Onset Graves' Disease
  Hoon Sung Choi, Won Sang Yoo
  Endocrinology and Metabolism.2017; 32(2): 281.     CrossRef
• The Second Antithyroid Drug Treatment Is Effective in Relapsed Graves' Disease Patients: A Median 11-Year Follow-Up Study
  Ye An Kim, Sun Wook Cho, Hoon Sung Choi, Shinje Moon, Jae Hoon Moon, Kyung Won Kim, Do Joon Park, Ka Hee Yi, Young Joo Park, Bo Youn Cho
  Thyroid.2017; 27(4): 491.     CrossRef
• The Recurrence Rate of Graves' Disease among Patients with Subclinical Thyrotoxicosis after Initial Remission with Antithyroid Agents
  Myoung Sook Shim, Soo Min Nam, Jin Sae Yoo, Hae Kyung Kim, Sang Jun Lee, Mi Young Lee
  International Journal of Thyroidology.2017; 10(2): 77.     CrossRef
• Articles inEndocrinology and Metabolismin 2016
  Won-Young Lee
  Endocrinology and Metabolism.2017; 32(1): 62.     CrossRef